{"meta":{"query_hash":"50e8e9314365","filters":{"venue":"Cancer Biotherapy and Radiopharmaceuticals"},"cohort_total":55,"direct_labels_cover":0,"predictions_cover":55,"exported":55,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/50e8e9314365","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Biotherapy+and+Radiopharmaceuticals"},"results":[{"id":"W1748514462","doi":"10.1089/cbr.2014.1736","title":"Innate and Adoptive Immune Cells Contribute to Natural Resistance to Systemic Metastasis of B16 Melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Metastasis; Melanoma; Immune system; Cytotoxic T cell; Cancer research; Immunology; Biology; CD8; Cancer; In vitro","score_opus":0.024686505494036358,"score_gpt":0.3128939068882811,"score_spread":0.2882074013942448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1748514462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7487825,0.24313803,0.00047448216,0.0021202413,0.0043103774,0.0007447783,0.00011971303,0.00004800478,0.0002618302],"genre_scores_gemma":[0.9862258,0.006723487,0.00013589881,0.0016348613,0.00004877537,0.000052103605,0.000011493826,0.000017986637,0.005149636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987897,0.00020560055,0.0003656066,0.00030618728,0.00004966917,0.0002831791],"domain_scores_gemma":[0.9993233,0.000098568766,0.00011457698,0.000161143,0.00019235091,0.000110026005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036268964,0.00019658313,0.00044771616,0.00014194295,0.00009144888,0.000020059097,0.00010875065,0.00013017545,0.00018015417],"category_scores_gemma":[0.000038066082,0.00015873912,0.000057306195,0.00020910928,0.00015068291,0.00010931854,0.000041927324,0.00021100967,0.000044251552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031784947,0.0000346042,0.0001263331,0.000055688295,0.0003843144,0.0000021340052,0.0011268203,0.000008043219,0.98213685,0.0003453437,0.006287579,0.006313828],"study_design_scores_gemma":[0.0021556413,0.00022292124,0.0002764045,0.00013110331,0.000063512736,0.000026905116,0.0003297713,0.000007779517,0.7073347,0.000008412538,0.28926623,0.00017664491],"about_ca_topic_score_codex":0.000052195952,"about_ca_topic_score_gemma":0.000006357007,"teacher_disagreement_score":0.28297865,"about_ca_system_score_codex":0.000097155316,"about_ca_system_score_gemma":0.00005198263,"threshold_uncertainty_score":0.6473194},"labels":[],"label_agreement":null},{"id":"W1965592891","doi":"10.1089/10849780252824028","title":"Antitumor Immune Responses Derived from Transgenic Expression of CD40 Ligand in Myeloma Cells","year":2002,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"CD40; Immune system; Biology; CD8; CD154; Cancer research; Molecular biology; Cytotoxic T cell; Cell biology; Immunology; In vitro; Biochemistry","score_opus":0.03081410268097728,"score_gpt":0.30244668452570345,"score_spread":0.27163258184472616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965592891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6899984,0.3087212,0.00004319931,0.00035026734,0.0004392722,0.0002695602,0.00010466195,0.00003078464,0.000042637712],"genre_scores_gemma":[0.85983926,0.13878612,0.00007419231,0.00034583415,0.000036705376,0.0000394478,0.000008044179,0.000031773903,0.00083861116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793196,0.0005393893,0.0006121617,0.00040834473,0.00005977017,0.00044836893],"domain_scores_gemma":[0.99899226,0.00045929567,0.00015710306,0.0003150367,0.00003500068,0.00004132049],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027179185,0.00030719134,0.0006457736,0.00021464881,0.00015130601,0.000018812225,0.00025891568,0.0003248753,0.0035933428],"category_scores_gemma":[0.000019387702,0.00025467915,0.00015125042,0.00024012283,0.00061724416,0.00016308027,0.000026789827,0.00035077272,0.000034194345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047164625,0.00023666126,0.0008987634,0.000039708102,0.00019237668,0.000009514406,0.002119348,0.000003798129,0.9693382,0.000015593501,0.00011875477,0.022310825],"study_design_scores_gemma":[0.005761082,0.00019737093,0.010221065,0.00025231444,0.00003828969,0.000013704154,0.00013788772,0.000019428782,0.95901513,0.000018071012,0.024025934,0.00029974815],"about_ca_topic_score_codex":0.00012401512,"about_ca_topic_score_gemma":0.0000048637107,"teacher_disagreement_score":0.16993508,"about_ca_system_score_codex":0.000038024016,"about_ca_system_score_gemma":0.000043582226,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W1966346234","doi":"10.1089/cbr.2005.20.401","title":"Vaccine of Engineered Tumor Cells Secreting Stromal Cell–Derived Factor-1 Induces T-Cell Dependent Antitumor Responses","year":2005,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Southern Medical University; Ohio State University","keywords":"Biology; CD8; In vivo; Transfection; CXC chemokine receptors; Cancer research; Immunology; Cell culture; Molecular biology; Chemokine; Immune system; Chemokine receptor","score_opus":0.01955147959924157,"score_gpt":0.2965968303704807,"score_spread":0.2770453507712391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966346234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8450623,0.1531996,0.00006836422,0.00032312048,0.000569457,0.00038753045,0.00024030994,0.00007175292,0.00007756647],"genre_scores_gemma":[0.9714553,0.026069827,0.00026681495,0.000604025,0.00012800487,0.00003486071,0.000013754429,0.00005326858,0.0013741431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774736,0.00045287795,0.0006390605,0.000458114,0.000088629335,0.000613939],"domain_scores_gemma":[0.9988441,0.00042146462,0.0002721565,0.0003074919,0.00007980841,0.00007498045],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035705836,0.00041643356,0.0006602952,0.0002280346,0.00023753117,0.000034016593,0.00031798426,0.0002604244,0.002527145],"category_scores_gemma":[0.0000213177,0.00035056254,0.0001600926,0.00018748657,0.0002662663,0.00020074658,0.000051512052,0.00046195832,0.000035198744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00401913,0.0002608416,0.000515578,0.00011187835,0.00026333355,0.000008625838,0.0008650085,0.00002299162,0.9844729,0.000018506573,0.00015115109,0.009290104],"study_design_scores_gemma":[0.005720778,0.0003592721,0.002180857,0.0000773278,0.00006372087,0.000043345455,0.00020631388,0.000018344585,0.9557174,0.000002066784,0.035216972,0.00039361796],"about_ca_topic_score_codex":0.000046701745,"about_ca_topic_score_gemma":0.000002156958,"teacher_disagreement_score":0.12712976,"about_ca_system_score_codex":0.00006754552,"about_ca_system_score_gemma":0.0001675311,"threshold_uncertainty_score":0.9998946},"labels":[],"label_agreement":null},{"id":"W1966889790","doi":"10.1089/cbr.2012.1390","title":"Can C-Arm Cone-Beam CT Detect a Micro-Embolic Effect After TheraSphere Radioembolization of Neuroendocrine and Carcinoid Liver Metastasis?","year":2013,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Philips Research Americas; Société Française de Radiologie","keywords":"Medicine; Hounsfield scale; Microsphere; Nuclear medicine; Metastasis; Radiology; Neuroendocrine tumors; Selective internal radiation therapy; Carcinoid tumors; Cancer; Hepatocellular carcinoma; Computed tomography; Pathology; Internal medicine","score_opus":0.030354107035187258,"score_gpt":0.29202129505692687,"score_spread":0.2616671880217396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966889790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85654426,0.14070983,0.0000139013555,0.0010316898,0.000095279356,0.0014585578,0.000046886704,0.00004111941,0.000058469337],"genre_scores_gemma":[0.9541992,0.043405425,0.00016278942,0.0015205429,0.00014821957,0.0003700339,0.000011635494,0.000055259447,0.00012687886],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984715,0.00019184225,0.0003267141,0.00043553853,0.00018214519,0.00039226084],"domain_scores_gemma":[0.99911684,0.00012874273,0.00009209453,0.00023092573,0.00007620799,0.00035521653],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012241626,0.00035735243,0.0007100297,0.00012093042,0.00007979661,0.000044587207,0.00006504362,0.000057134963,0.0013694412],"category_scores_gemma":[0.0000116146675,0.0002580174,0.00015008626,0.00022314693,0.0002932159,0.00011327629,0.00002463967,0.00018702008,0.0000060962984],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011103709,0.00017023283,0.48045835,0.00085560506,0.0009111269,0.000356383,0.0003852469,6.91328e-7,0.35366768,0.00002001961,0.00020255822,0.16186173],"study_design_scores_gemma":[0.007859444,0.0011502585,0.07580754,0.00015944193,0.0010193043,0.0006097607,0.000023151957,0.000850746,0.9046448,0.000021992499,0.007494851,0.0003587406],"about_ca_topic_score_codex":0.0004314147,"about_ca_topic_score_gemma":0.000009524571,"teacher_disagreement_score":0.5509771,"about_ca_system_score_codex":0.000055896075,"about_ca_system_score_gemma":0.00006262161,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W1968993470","doi":"10.1089/cbr.2008.0553","title":"<sup>111</sup> In-Labeled Immunoconjugates (ICs) Bispecific for the Epidermal Growth Factor Receptor (EGFR) and Cyclin-Dependent Kinase Inhibitor, p27 <sup>Kip1</sup>","year":2009,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Internalization; Epidermal growth factor receptor; Molecular biology; Chemistry; Kinase; Epidermal growth factor; Trastuzumab; Cancer research; Receptor; Biology; Biochemistry; Cancer","score_opus":0.057479573944970046,"score_gpt":0.38831058519363243,"score_spread":0.3308310112486624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968993470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8351803,0.13032773,0.00016349145,0.029444791,0.00040226543,0.0038318501,0.000397855,0.00012588581,0.00012583863],"genre_scores_gemma":[0.83142334,0.1583752,0.00043759303,0.006680226,0.0017834937,0.00050798844,0.000026454501,0.000114738665,0.000650974],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957268,0.00031583838,0.0009401975,0.001068522,0.00067372253,0.0012748684],"domain_scores_gemma":[0.99728024,0.001074383,0.00015030536,0.00053539843,0.00024860448,0.00071109063],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001182917,0.0006486421,0.0010273616,0.00032728183,0.0004423446,0.00021387539,0.00037576474,0.00042963264,0.0011896633],"category_scores_gemma":[0.00016956776,0.0004608538,0.00022367736,0.00054755,0.00078024965,0.00027397307,0.00007522557,0.0010976617,0.000022203494],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014842321,0.0014060932,0.031139495,0.0014597713,0.0012795686,0.00018808457,0.006064998,0.0002495026,0.46992385,0.0013574404,0.012846412,0.45924246],"study_design_scores_gemma":[0.05114567,0.0041305483,0.018317023,0.0016947006,0.0005166474,0.00025701625,0.0016076356,0.029040473,0.37070307,0.0008414866,0.519409,0.002336748],"about_ca_topic_score_codex":0.0001521198,"about_ca_topic_score_gemma":0.00000929367,"teacher_disagreement_score":0.5065626,"about_ca_system_score_codex":0.0005207508,"about_ca_system_score_gemma":0.0004067306,"threshold_uncertainty_score":0.9997843},"labels":[],"label_agreement":null},{"id":"W1975076291","doi":"10.1089/cbr.2008.0579","title":"Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration","year":2009,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Immunotoxin; Medicine; Systemic administration; SAFER; Epithelial cell adhesion molecule; Administration (probate law); Pharmacology; Cancer; Internal medicine; Immunology; Antibody; Monoclonal antibody; Computer science; Computer security","score_opus":0.039229123685385794,"score_gpt":0.39258485531572296,"score_spread":0.3533557316303372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975076291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98190886,0.013763447,0.0013594658,0.0010018122,0.00064365665,0.0010496572,0.00012062624,0.000051428695,0.00010106304],"genre_scores_gemma":[0.9906288,0.0062344926,0.00090557145,0.0017521622,0.0001270438,0.00008702898,0.000029857596,0.000018306073,0.00021678407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819994,0.00029392395,0.00057879946,0.00048112814,0.0000911678,0.00035502782],"domain_scores_gemma":[0.9992081,0.00011472656,0.00019175935,0.00027539118,0.00011123906,0.00009876189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042243896,0.0002677847,0.0005059485,0.00011918833,0.00015765529,0.000033002296,0.00025836652,0.00026216675,0.00043631395],"category_scores_gemma":[0.000016153113,0.00021941734,0.00011195269,0.00013653192,0.00022726932,0.00021740475,0.000026526413,0.0003031136,0.00000988834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093260105,0.00039442696,0.000548025,0.00003714987,0.00024550536,0.0000056207728,0.00030408904,0.00003867583,0.9474256,0.0026722932,0.00009568714,0.047300316],"study_design_scores_gemma":[0.005472196,0.0042848624,0.035586942,0.000415164,0.00013749303,0.00017230523,0.00024772773,0.0005615258,0.9386937,0.00025169106,0.013556175,0.00062018563],"about_ca_topic_score_codex":0.000025703996,"about_ca_topic_score_gemma":0.0000028701343,"teacher_disagreement_score":0.04668013,"about_ca_system_score_codex":0.000083142346,"about_ca_system_score_gemma":0.00023686938,"threshold_uncertainty_score":0.894758},"labels":[],"label_agreement":null},{"id":"W1978030368","doi":"10.1089/108497802760804745","title":"Flux Through Multicellular Layers of a Technetium-99m-Nitroimidazole for Imaging Hypoxia","year":2002,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Medical Research Council; Medical Research Council Canada","keywords":"Hypoxia (environmental); Nitroimidazole; Chemistry; Population; Metabolism; Technetium; Oxygen; Flux (metallurgy); Biochemistry; Biophysics; Radiochemistry; Biology; Medicine; Nuclear chemistry","score_opus":0.03282947349751262,"score_gpt":0.32631579221871515,"score_spread":0.2934863187212025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978030368","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47449744,0.51111364,0.00833353,0.0016194938,0.0018176236,0.0012853467,0.00031067323,0.00005680243,0.00096544216],"genre_scores_gemma":[0.86247855,0.1267454,0.0036507878,0.0029509626,0.0024489586,0.00024848952,0.00003152464,0.00008731781,0.001357975],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986643,0.000043259362,0.0003059976,0.00045523627,0.00012763128,0.0004035829],"domain_scores_gemma":[0.99934185,0.000031336618,0.00011437367,0.0002846558,0.000088928165,0.00013885503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015535128,0.00024991744,0.0003338997,0.000053170854,0.00011578204,0.000023868202,0.00018126043,0.00015017575,0.00023720751],"category_scores_gemma":[0.000023458484,0.00022955076,0.00017123428,0.0001234838,0.000318299,0.000014087766,0.000034249355,0.00010866063,0.0000021778433],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002434872,0.0000850414,0.00023020529,0.000105382795,0.00014743512,7.398627e-7,0.00018651712,0.000033081706,0.95317507,0.00015866163,0.0058476664,0.039786696],"study_design_scores_gemma":[0.0020975182,0.0000605726,0.000064899774,0.000021945363,0.00006724376,0.0000103395005,0.000043839478,0.0011105953,0.44969758,0.000042322674,0.54657745,0.00020565838],"about_ca_topic_score_codex":0.000023298357,"about_ca_topic_score_gemma":0.0000029761989,"teacher_disagreement_score":0.5407298,"about_ca_system_score_codex":0.000018531016,"about_ca_system_score_gemma":0.00003714874,"threshold_uncertainty_score":0.9360808},"labels":[],"label_agreement":null},{"id":"W1989861712","doi":"10.1089/cbr.2007.368-r","title":"Review: Cancer Immunotherapy by Exosome-Based Vaccines","year":2007,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Immunotherapy; Exosome; Immune system; Cancer immunotherapy; Cytotoxic T cell; Microvesicles; Cancer; Cancer research; Antigen; Immunology; CD8; Dendritic cell; Tumor antigen; Medicine; Biology; In vitro; Internal medicine; microRNA","score_opus":0.05512507250976998,"score_gpt":0.4479299156398748,"score_spread":0.3928048431301048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989861712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004312119,0.9965401,0.0002582823,0.00035433524,0.0005503402,0.001541987,0.000597034,0.00006973126,0.00004505833],"genre_scores_gemma":[0.0000042636634,0.98522973,0.0001378689,0.011670256,0.0010408772,0.00068877015,0.00028804873,0.0002916006,0.00064858934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696493,0.0002957382,0.0008241974,0.0010315973,0.00023070021,0.00065281487],"domain_scores_gemma":[0.9983012,0.00007338763,0.00039231556,0.0007371531,0.00009215197,0.000403794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049131236,0.0008491151,0.0015204842,0.0001130125,0.000118008735,0.000052447576,0.00055956934,0.00067948544,0.00050427497],"category_scores_gemma":[0.000022525775,0.0006819933,0.00064021413,0.00032776513,0.00029291149,0.000008344336,0.000056390047,0.00042808795,0.000007733305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012276886,0.000112909795,0.000017436736,0.021093035,0.0006461768,0.0000089601845,0.0000036063582,6.3014875e-7,0.010834121,0.0000049665086,0.04641999,0.9207354],"study_design_scores_gemma":[0.0011160529,0.000082822524,9.906191e-7,0.012840724,0.0006336317,0.000017176411,9.583513e-7,0.000004993178,0.006120126,0.000002651212,0.97833955,0.0008403031],"about_ca_topic_score_codex":0.00001562911,"about_ca_topic_score_gemma":0.0000027890096,"teacher_disagreement_score":0.9319196,"about_ca_system_score_codex":0.00010929706,"about_ca_system_score_gemma":0.00051680155,"threshold_uncertainty_score":0.9995631},"labels":[],"label_agreement":null},{"id":"W1993243559","doi":"10.1089/cbr.2000.15.339","title":"<i>In Vitro</i> Comparison of Sestamibi, Tetrofosmin, and Furifosmin as Agents for Functional Imaging of Multidrug Resistance in Tumors","year":2000,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto","keywords":"Multiple drug resistance; In vitro; Medicine; Medical physics; Pharmacology; Nuclear medicine; Drug resistance; Biology; Genetics","score_opus":0.028927514621131602,"score_gpt":0.3684227733358898,"score_spread":0.3394952587147582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993243559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96053004,0.036956012,0.00012242263,0.0012402354,0.00010997382,0.000620629,0.00008269162,0.000010367553,0.00032763794],"genre_scores_gemma":[0.9889084,0.00807553,0.0010768397,0.00083420455,0.00006400804,0.000051304825,0.0000099844965,0.000022815782,0.0009569271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987341,0.000031309653,0.000496146,0.0003009746,0.00017870369,0.00025877182],"domain_scores_gemma":[0.99955535,0.00008860801,0.00008868071,0.0001101222,0.00003965348,0.00011758914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023065346,0.00016888055,0.00056587876,0.00014164446,0.000036073743,0.000005250541,0.000049526192,0.00006762965,0.00020680334],"category_scores_gemma":[0.0000067032106,0.00014473883,0.00006961586,0.00020369835,0.00024165247,0.00008254307,0.000003714548,0.0001451008,3.6405388e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015702264,0.0006606562,0.090358004,0.0015155976,0.00010657301,0.00004981821,0.0018210397,0.000038279475,0.852861,0.00048641904,0.00038315658,0.036017183],"study_design_scores_gemma":[0.016403629,0.00014325195,0.05998142,0.0010434731,0.00011385315,0.000014449604,0.00038315041,0.0021591943,0.88618416,0.00040371282,0.032836583,0.00033312693],"about_ca_topic_score_codex":0.000052488984,"about_ca_topic_score_gemma":0.000030111049,"teacher_disagreement_score":0.035684057,"about_ca_system_score_codex":0.00004977755,"about_ca_system_score_gemma":0.000077693796,"threshold_uncertainty_score":0.59022784},"labels":[],"label_agreement":null},{"id":"W1993742651","doi":"10.1089/cbr.2006.21.146","title":"Intradermal Vaccination of Dendritic Cell–Derived Exosomes Is Superior to a Subcutaneous One in the Induction of Antitumor Immunity","year":2006,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research; Saskatchewan Health Research Foundation; National Institutes of Health; University of Saskatchewan","keywords":"Vaccination; Microvesicles; Immunology; Immunity; Medicine; Dendritic cell; Immune system; Cell mediated immunity; Immunotherapy; Biology","score_opus":0.022478847394798766,"score_gpt":0.30342283462827313,"score_spread":0.28094398723347436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993742651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9296488,0.068165176,0.0000495607,0.0013152206,0.00023838051,0.00046978504,0.00004780078,0.000012888123,0.000052400625],"genre_scores_gemma":[0.9871742,0.011943413,0.000055734585,0.00059659453,0.000036386304,0.00004258443,0.000009771436,0.000015431357,0.00012588684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985614,0.0004302039,0.00046964822,0.00020139708,0.0000618601,0.00027549645],"domain_scores_gemma":[0.9993821,0.00021203134,0.000119315104,0.0002107722,0.00006137721,0.000014428271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032771198,0.00017413979,0.000393824,0.00020219812,0.00012075242,0.000013722125,0.00021447758,0.0001727488,0.0006439924],"category_scores_gemma":[0.000011380238,0.00013495427,0.00007768834,0.0003297613,0.0002581722,0.00010621289,0.000018326155,0.00025573786,0.0000042086886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017906904,0.00036607237,0.0012127096,0.00009750524,0.000086579916,0.000003707312,0.0025502434,0.000007030725,0.979456,0.0002045299,0.0000688839,0.014156067],"study_design_scores_gemma":[0.0023384062,0.00037242126,0.047385093,0.00006909292,0.000040162813,0.000088435,0.00045845486,0.0000051028624,0.9451966,0.000057312678,0.0038338967,0.00015498312],"about_ca_topic_score_codex":0.00046655882,"about_ca_topic_score_gemma":0.00001475015,"teacher_disagreement_score":0.05752541,"about_ca_system_score_codex":0.00003882485,"about_ca_system_score_gemma":0.000068327055,"threshold_uncertainty_score":0.7051265},"labels":[],"label_agreement":null},{"id":"W1999142044","doi":"10.1089/cbr.2004.19.627","title":"Preclinical Investigations of Drug and Radionuclide Conjugates of Bisphosphonates for the Treatment of Metastatic Bone Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Bone health and treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bisphosphonate; Conjugate; Medicine; Chemotherapy; In vivo; Therapeutic index; Toxicity; Pharmacology; Distribution (mathematics); Fluorouracil; Pharmacokinetics; Radiation therapy; Drug; Internal medicine; Osteoporosis; Biology","score_opus":0.08922485021045369,"score_gpt":0.44293684926101,"score_spread":0.35371199905055634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999142044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7366067,0.25558147,0.0000411177,0.0063864645,0.0000945672,0.0010447797,0.00023325038,0.0000068412696,0.0000048078878],"genre_scores_gemma":[0.7478964,0.24940796,0.001757797,0.0005755025,0.000027163096,0.00022830686,0.000005236627,0.00001408098,0.000087585955],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999057,0.00003151422,0.00046087988,0.00018189588,0.0001043201,0.00016440364],"domain_scores_gemma":[0.9988619,0.0005545977,0.00018459467,0.00013234322,0.00008528324,0.00018128839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014501871,0.0001414968,0.0005434735,0.00004714167,0.00006745133,0.000003386203,0.000031164956,0.000047474317,0.00005087171],"category_scores_gemma":[0.000022466542,0.00008122681,0.00009902107,0.00011933672,0.00069207116,0.000034050234,0.000004075889,0.000050116865,1.1462526e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014401057,0.0057898066,0.32425544,0.0060551283,0.009834151,0.000017801836,0.014167636,0.00039107483,0.17412095,0.008102928,0.00041967473,0.44244435],"study_design_scores_gemma":[0.03172825,0.0023961703,0.032960705,0.00063346175,0.0022703642,0.00002631896,0.00019959708,0.0006273135,0.9077959,0.001513347,0.019659705,0.00018885809],"about_ca_topic_score_codex":0.0010637802,"about_ca_topic_score_gemma":0.000059577844,"teacher_disagreement_score":0.73367494,"about_ca_system_score_codex":0.000054793672,"about_ca_system_score_gemma":0.00026874468,"threshold_uncertainty_score":0.33123332},"labels":[],"label_agreement":null},{"id":"W1999287766","doi":"10.1089/108497802320970217","title":"Advances in Dendritic Cell-Based Vaccine of Cancer","year":2002,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Antigen; CTL*; Dendritic cell; In vivo; Immunology; Biology; Immune system; Chemokine; Cancer research; Antigen-presenting cell; Tumor antigen; In vitro; Immunotherapy; T cell; CD8","score_opus":0.03928933383198763,"score_gpt":0.39346241476117694,"score_spread":0.3541730809291893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999287766","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002404787,0.9972917,0.000016317419,0.00010291209,0.0010409039,0.0008889048,0.00023737394,0.000038033348,0.0001433629],"genre_scores_gemma":[0.0005752816,0.99758124,0.000020322539,0.00031292118,0.0000760053,0.0004178717,0.000029260804,0.00008480157,0.0009023005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997051,0.000675145,0.0010190851,0.0005778609,0.00006346763,0.000613425],"domain_scores_gemma":[0.9985069,0.0006057282,0.0004310952,0.00036054105,0.00004887364,0.000046838693],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027701934,0.0006392904,0.0023533306,0.0004694802,0.000110904155,0.000016460694,0.00038934793,0.000743838,0.004168274],"category_scores_gemma":[0.000014808873,0.0004902224,0.0004071806,0.0005058676,0.00038804085,0.00013343937,0.000029503917,0.0007423166,0.000027612006],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044269607,0.00023948512,0.00007660016,0.009614099,0.00031928485,0.00000919911,0.00008843793,0.000005846856,0.00443474,0.000029372026,0.00015571546,0.9845845],"study_design_scores_gemma":[0.0034918636,0.00014949698,0.0000139943895,0.008480228,0.00043871705,0.000021157448,0.000011008848,0.0000058656356,0.011060133,0.0000048291727,0.9757946,0.00052809267],"about_ca_topic_score_codex":0.000075474585,"about_ca_topic_score_gemma":0.000013749481,"teacher_disagreement_score":0.9840564,"about_ca_system_score_codex":0.00014325838,"about_ca_system_score_gemma":0.00029953255,"threshold_uncertainty_score":0.99975497},"labels":[],"label_agreement":null},{"id":"W1999849102","doi":"10.1089/cbr.2000.15.561","title":"Accuracy of Gamma Probes in Localizing Radioactivity: In-Vitro Assessment and Clinical Implications","year":2000,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Gamma probe; Nuclear medicine; Full width at half maximum; Gamma ray; Technetium; Gamma camera; Sentinel lymph node; Chemistry; Medicine; Physics; Optics; Cancer; Nuclear physics","score_opus":0.041071631844506795,"score_gpt":0.4550022861993674,"score_spread":0.4139306543548606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999849102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97170746,0.013798844,0.0109776845,0.0018755136,0.000055612407,0.00087989203,0.00006696708,0.00004140955,0.00059663993],"genre_scores_gemma":[0.9549368,0.037062842,0.0073295888,0.00033265157,0.00013838285,0.00013894406,0.0000039290794,0.000026097774,0.000030779454],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986287,0.00014710617,0.0004912625,0.00037404575,0.000082352584,0.00027656736],"domain_scores_gemma":[0.9992481,0.00030580047,0.00011435765,0.0001977597,0.000019390884,0.00011457784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034345468,0.00018651938,0.00044578066,0.000103120685,0.000051819323,0.000023832907,0.00011226723,0.000081096914,0.00037780148],"category_scores_gemma":[0.0000028937443,0.00016767434,0.00006456575,0.00024170488,0.00031192115,0.00022627076,0.000014575185,0.0003125532,1.9853265e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016743285,0.00023063483,0.21945314,0.000024267485,0.00007044833,0.0000011477867,0.00011355218,0.000023623512,0.049782667,0.0015593489,0.000013792211,0.7285599],"study_design_scores_gemma":[0.01780401,0.0005086057,0.49002874,0.0006689323,0.00015771949,0.000023006207,0.00019303797,0.017388834,0.32635796,0.013162738,0.13183437,0.0018720313],"about_ca_topic_score_codex":0.00014193585,"about_ca_topic_score_gemma":0.0000040315817,"teacher_disagreement_score":0.7266879,"about_ca_system_score_codex":0.000071394694,"about_ca_system_score_gemma":0.000096399315,"threshold_uncertainty_score":0.6837561},"labels":[],"label_agreement":null},{"id":"W2000526872","doi":"10.1089/cbr.2009.0706","title":"The <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity of Adenovirus-Mediated Interleukin-24 Expression for Laryngocarcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; In vivo; Angiogenesis; Apoptosis; Downregulation and upregulation; In vitro; Cell growth; Cell culture; Biology; Gene","score_opus":0.020963673325935885,"score_gpt":0.34511288956079883,"score_spread":0.3241492162348629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000526872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98124045,0.016995523,0.000028836246,0.00078386563,0.00020043166,0.0005872445,0.0001302104,0.000005821966,0.000027630902],"genre_scores_gemma":[0.97720104,0.021753902,0.00009708659,0.0005334284,0.0001584705,0.00014657837,0.00000557621,0.000028354236,0.000075549324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880904,0.00011559989,0.0002282017,0.00037466534,0.00011607977,0.00035641732],"domain_scores_gemma":[0.99937344,0.00014820484,0.00007147932,0.00024723553,0.000041360247,0.00011828309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005383243,0.00017649279,0.0002396241,0.000070550945,0.000091714,0.000027461507,0.00019607025,0.0001695402,0.000021504506],"category_scores_gemma":[0.00003918228,0.00012870303,0.00005763525,0.00012921898,0.0004249651,0.000011349912,0.000051818082,0.0002623503,2.4837914e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012375567,0.000076809614,0.002224107,0.000052078372,0.000029805493,0.000002335198,0.000051902913,0.000001976152,0.97103,0.0000075371768,0.00016671437,0.013981189],"study_design_scores_gemma":[0.0028851575,0.00039038502,0.0009693148,0.000023764853,0.0000057962593,0.000005168153,0.00001506552,0.00032696387,0.9674008,0.000021132531,0.027804919,0.00015154484],"about_ca_topic_score_codex":0.000019389618,"about_ca_topic_score_gemma":0.00025388107,"teacher_disagreement_score":0.027638203,"about_ca_system_score_codex":0.000014540575,"about_ca_system_score_gemma":0.000100250996,"threshold_uncertainty_score":0.52483577},"labels":[],"label_agreement":null},{"id":"W2007734777","doi":"10.1089/cbr.2000.15.15","title":"Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study Results","year":2000,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"","keywords":"Radioimmunotherapy; Pretargeting; Medicine; Biodistribution; Conjugate; Nuclear medicine; Rituximab; Lymphoma; Pharmacokinetics; Antibody; Internal medicine; Chemistry; Monoclonal antibody; Immunology","score_opus":0.07038171382198578,"score_gpt":0.4769027952507788,"score_spread":0.406521081428793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007734777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965618,0.028058326,0.00004146552,0.0021863123,0.00017670613,0.0027859914,0.0006243191,0.000039096314,0.00046976266],"genre_scores_gemma":[0.9149006,0.076385655,0.00054541265,0.0008915407,0.0007625818,0.00040453312,0.000060429273,0.000055544835,0.0059937113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796426,0.00010425409,0.0006022078,0.00051331444,0.0003168395,0.00049912767],"domain_scores_gemma":[0.9989678,0.00020464555,0.0000920373,0.0003049988,0.000110927904,0.000319545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002682493,0.0003441723,0.0008317921,0.00013479167,0.00027251424,0.00002934025,0.00011561645,0.00013858116,0.0012290032],"category_scores_gemma":[0.000008855335,0.00024234423,0.00024443763,0.00023519057,0.00035345476,0.000108337554,0.000010677955,0.00007424925,0.000003620684],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07664491,0.0064212037,0.00071935187,0.00013283033,0.0014188503,0.00006746934,0.003154371,0.00000569163,0.10329925,0.000021850861,0.00045138883,0.80766284],"study_design_scores_gemma":[0.1280711,0.042350616,0.004727974,0.00014397869,0.00037025384,0.000098235105,0.00014665567,0.002895204,0.18203838,0.000029333723,0.63866776,0.00046049734],"about_ca_topic_score_codex":0.00022301024,"about_ca_topic_score_gemma":0.0000048780503,"teacher_disagreement_score":0.80720234,"about_ca_system_score_codex":0.00011694206,"about_ca_system_score_gemma":0.00021608983,"threshold_uncertainty_score":0.99968404},"labels":[],"label_agreement":null},{"id":"W2008981569","doi":"10.1089/cbr.2006.370","title":"Adenovirus-Mediated Il-24 Expression Suppresses Hepatocellular Carcinoma Growth via Induction of Cell Apoptosis and Cycling Arrest and Reduction of Angiogenesis","year":2007,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; Angiogenesis; Apoptosis; Genetic enhancement; Downregulation and upregulation; Cell cycle checkpoint; Tumor suppressor gene; Biology; Cell growth; Cell cycle; In vivo; Immunology; Cancer; Carcinogenesis; Gene","score_opus":0.02577899400236391,"score_gpt":0.31735752925913036,"score_spread":0.29157853525676647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008981569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9492504,0.049710177,0.00036512042,0.00009719667,0.00017903073,0.0003174762,0.000060142695,0.000009122647,0.000011361169],"genre_scores_gemma":[0.94561476,0.053722188,0.0002655175,0.00006270964,0.00024620656,0.000018025767,0.000022585713,0.000032808814,0.000015204205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866444,0.0001223154,0.00033572482,0.00041791887,0.00017950508,0.00028008944],"domain_scores_gemma":[0.9993262,0.00004436437,0.000145535,0.00018330582,0.000114103495,0.00018647179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004434447,0.00020333128,0.00027308386,0.00015069064,0.00009736708,0.000013303222,0.0000940165,0.0002389932,0.000028290502],"category_scores_gemma":[0.000015920963,0.00018458182,0.00005891686,0.00019389771,0.0004243357,0.000014747874,0.000046114023,0.00011544928,1.9663192e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003005553,0.00007345658,0.014539873,0.00023435146,0.00008458079,0.0000012406974,0.00019284009,0.000004533178,0.9755462,0.0000020413995,0.000031246458,0.00628412],"study_design_scores_gemma":[0.00146075,0.0006847499,0.0018358134,0.000041895983,0.00003938591,0.000009712651,0.0001107294,0.000103820996,0.9951376,0.000018651508,0.00036339433,0.00019354062],"about_ca_topic_score_codex":0.000054389966,"about_ca_topic_score_gemma":0.0000036122515,"teacher_disagreement_score":0.019591391,"about_ca_system_score_codex":0.000017146307,"about_ca_system_score_gemma":0.000049904407,"threshold_uncertainty_score":0.7527028},"labels":[],"label_agreement":null},{"id":"W2010664444","doi":"10.1089/cbr.2011.1047","title":"Synergistic Tumor Suppression by Adenovirus-Mediated Inhibitor of Growth 4 and Interleukin-24 Gene Cotransfer in Hepatocarcinoma Cells","year":2011,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Government of Jiangsu Province; National Science Foundation","keywords":"Cancer research; Angiogenesis; Fas ligand; Downregulation and upregulation; Tumor suppressor gene; Biology; Vascular endothelial growth factor; Genetic enhancement; Apoptosis; Cancer; Carcinogenesis; Programmed cell death; Gene","score_opus":0.02856794852973225,"score_gpt":0.3058836997644912,"score_spread":0.27731575123475893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010664444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96136504,0.03757063,0.00009333242,0.000107037806,0.00016629061,0.0003991641,0.00023970127,0.000010313374,0.00004846502],"genre_scores_gemma":[0.9681197,0.030826041,0.0000794659,0.00068672653,0.00010978421,0.00006479483,0.000026144973,0.00004441806,0.00004292183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845517,0.00017901725,0.0003462556,0.00048279803,0.00016059807,0.00037617944],"domain_scores_gemma":[0.9994113,0.00003849426,0.00006090855,0.00020653264,0.000049943268,0.00023283268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021739297,0.0002502667,0.00032027793,0.00011043493,0.000048383765,0.000014463586,0.00018448962,0.00017742765,0.00018764721],"category_scores_gemma":[0.000014208862,0.00021505948,0.000056856414,0.00015904667,0.0004624679,0.00001114117,0.000048613903,0.00019109741,0.0000015019701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052391444,0.00014707865,0.0066152276,0.00011743576,0.000090248934,0.000015387295,0.00024384217,9.95592e-7,0.9855575,0.000007802924,0.00037157926,0.0015937343],"study_design_scores_gemma":[0.0027184144,0.0012890956,0.0007429995,0.000056177476,0.000020216437,0.0000063330945,0.000025291316,0.00012727093,0.9932465,0.000016661743,0.0014976886,0.0002533423],"about_ca_topic_score_codex":0.00007955655,"about_ca_topic_score_gemma":0.000026310829,"teacher_disagreement_score":0.007688985,"about_ca_system_score_codex":0.00002199665,"about_ca_system_score_gemma":0.00008892065,"threshold_uncertainty_score":0.8769871},"labels":[],"label_agreement":null},{"id":"W2011876126","doi":"10.1089/cbr.2005.20.260","title":"Significant Tumor Regression Induced by Microencapsulation of Recombinant Tumor Cells Secreting Fusion Protein","year":2005,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Fusion protein; Tumor necrosis factor alpha; Antigen; Cytotoxic T cell; Antibody; Cancer research; Cytokine; Monoclonal antibody; Recombinant DNA; Molecular biology; Immunotherapy; Fusion gene; In vitro; Chemistry; Biology; Immune system; Immunology; Biochemistry; Gene","score_opus":0.035192723681609375,"score_gpt":0.36757423292700575,"score_spread":0.3323815092453964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011876126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98296094,0.011443063,0.000016291304,0.0043735914,0.00014749488,0.0008369066,0.000042459746,0.000027299904,0.00015192592],"genre_scores_gemma":[0.9899555,0.0065678637,0.0008245639,0.0011633887,0.0002992626,0.00004855795,0.00001675688,0.000029658544,0.0010944444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984193,0.0001188242,0.00042368795,0.0003497663,0.00032726536,0.00036119556],"domain_scores_gemma":[0.9992415,0.000066615,0.00015743494,0.000147965,0.00009748223,0.00028902263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036204842,0.00021277288,0.00041268108,0.00010154821,0.00013516539,0.000017689534,0.00008963063,0.00008533225,0.00060934835],"category_scores_gemma":[0.000017541619,0.00014419062,0.00009162927,0.00019447287,0.00018079777,0.00008358157,0.000032123975,0.0003076077,0.0000072183307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015010784,0.0001771227,0.0010265083,0.0003037332,0.000050501672,0.000013938077,0.00016659423,0.0000011763643,0.9466982,0.00005660238,0.00077762146,0.049226947],"study_design_scores_gemma":[0.0019491852,0.00034183468,0.0010283755,0.00057212193,0.000029134917,0.00002191871,0.000034321965,0.0011708967,0.92609173,0.00001575567,0.06857552,0.00016919037],"about_ca_topic_score_codex":0.000102167745,"about_ca_topic_score_gemma":0.0000012868423,"teacher_disagreement_score":0.06779789,"about_ca_system_score_codex":0.000081196165,"about_ca_system_score_gemma":0.000114437404,"threshold_uncertainty_score":0.6671937},"labels":[],"label_agreement":null},{"id":"W2014028676","doi":"10.1089/cbr.2007.334","title":"Antitumor Effect of Large Doses IL-2-Activated HLA Haploidentical Peripheral Blood Stem Cells on Refractory Metastatic Solid Tumor Treatment","year":2007,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Vanderbilt University Medical Center","keywords":"Medicine; Immunotherapy; Refractory (planetary science); IL-2 receptor; Oncology; Immunology; Internal medicine; Immune system; Cancer research; T cell; Biology","score_opus":0.021575879480840155,"score_gpt":0.3482337635127965,"score_spread":0.32665788403195634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014028676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813189,0.014921118,0.00010905839,0.00009360412,0.002706445,0.00053180085,0.00005677718,0.00007149422,0.00019083828],"genre_scores_gemma":[0.9904394,0.0062110657,0.000013833392,0.00053943077,0.00009210327,0.00003719923,0.000016798538,0.00003687911,0.0026132893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818593,0.00036042402,0.00048222727,0.00039608506,0.00007212877,0.0005032227],"domain_scores_gemma":[0.9990624,0.0004022876,0.00018806923,0.00021190172,0.000053829874,0.000081492915],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044259633,0.00034724732,0.0006276813,0.00016331389,0.00019909165,0.000023527806,0.00010161679,0.00014612758,0.0024598062],"category_scores_gemma":[0.000011219568,0.00024533027,0.00018900361,0.00014806309,0.00027587076,0.00013281834,0.000015990572,0.00031401298,0.000052595697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055314302,0.00076442416,0.0005015196,0.00009339032,0.00105883,0.000033591357,0.0002903508,0.0000040087084,0.9824138,0.000100487414,0.00033335373,0.008874755],"study_design_scores_gemma":[0.0070363246,0.002872566,0.0004423541,0.00008544756,0.00025216443,0.000068661604,0.00011711698,0.000016882886,0.89236724,0.0000013382253,0.0965189,0.00022100203],"about_ca_topic_score_codex":0.000035101457,"about_ca_topic_score_gemma":0.000003150885,"teacher_disagreement_score":0.09618554,"about_ca_system_score_codex":0.00013909343,"about_ca_system_score_gemma":0.00004796979,"threshold_uncertainty_score":0.9999999},"labels":[],"label_agreement":null},{"id":"W2014641713","doi":"10.1089/cbr.2008.0461","title":"Inhibition of Pancreatic Carcinoma Growth by Adenovirus-Mediated Human Interleukin-24 Expression in Animal Model","year":2008,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; Genetic enhancement; Angiogenesis; Vascular endothelial growth factor; Tumor suppressor gene; Biology; Carcinoma; Pancreatic cancer; Pancreatic tumor; Pancreatic disease; Pancreas; Pathology; Medicine; Carcinogenesis; Endocrinology; Gene; Cancer; VEGF receptors","score_opus":0.03924960948422688,"score_gpt":0.346714339785522,"score_spread":0.3074647303012951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014641713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755955,0.023551064,0.00011233766,0.00018282945,0.00003356755,0.00032055168,0.000117966374,0.000012171386,0.000074066906],"genre_scores_gemma":[0.97657424,0.022350727,0.000085063606,0.0005813638,0.000104412815,0.000075256896,0.00007048173,0.000039344086,0.000119124525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985609,0.0001476853,0.0003362733,0.00041931076,0.00019692713,0.00033887307],"domain_scores_gemma":[0.99946946,0.000021716802,0.00008366334,0.00019928112,0.00006640752,0.0001595003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019422927,0.0002166253,0.00029069275,0.00011820419,0.00009629059,0.000009667698,0.00014274726,0.00020344103,0.000092587485],"category_scores_gemma":[0.000013997615,0.00019541317,0.0000688552,0.00017338399,0.00037872905,0.000013937956,0.000044397762,0.0001940827,0.0000013694303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032654859,0.00014136068,0.008593903,0.00006251311,0.000041845957,0.000009088895,0.00024784182,0.000025402338,0.98621374,0.0000069475445,0.001002725,0.000389163],"study_design_scores_gemma":[0.0029906149,0.0011500969,0.0010948622,0.000054363547,0.000009975724,0.000009508594,0.000022882348,0.0009925799,0.9929687,0.000026005013,0.0004578011,0.00022263214],"about_ca_topic_score_codex":0.000032832195,"about_ca_topic_score_gemma":0.000016971364,"teacher_disagreement_score":0.007499041,"about_ca_system_score_codex":0.000050453873,"about_ca_system_score_gemma":0.00011183348,"threshold_uncertainty_score":0.7968718},"labels":[],"label_agreement":null},{"id":"W2020835690","doi":"10.1089/cbr.2011.1148","title":"<i>In Vitro</i> and <i>In Vivo</i> Evaluation of [ <sup>18</sup> F]F-GAZ, a Novel Oxygen-Mimetic Azomycin-Glucose Conjugate, for Imaging Hypoxic Tumor","year":2012,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Cancer Foundation","keywords":"Biodistribution; In vivo; Chemistry; Imaging agent; In vitro; Excretion; Hypoxia (environmental); Radiochemistry; Nuclear medicine; Oxygen; Medicine; Biochemistry; Biology","score_opus":0.03236497458322271,"score_gpt":0.3457569114464636,"score_spread":0.31339193686324085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020835690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7899609,0.20766476,0.0002679463,0.00032375276,0.00049352495,0.0009819451,0.00020274767,0.0000071151712,0.000097283286],"genre_scores_gemma":[0.96512556,0.02963364,0.00072472106,0.0027881623,0.0012300371,0.00035653717,0.00001577176,0.000049663435,0.00007593541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982193,0.00012321345,0.0004307456,0.00046837112,0.00020775267,0.0005506041],"domain_scores_gemma":[0.99926245,0.00006251247,0.00012667656,0.00022262147,0.000110749825,0.00021499679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011654673,0.00028200523,0.00043868527,0.00013348632,0.00006185161,0.000023196711,0.00011831704,0.00012807382,0.000084513376],"category_scores_gemma":[0.00005268158,0.0002666011,0.00009854543,0.00017923837,0.0002401676,0.0000379663,0.000037430378,0.00012341668,4.4573204e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010358366,0.00017419302,0.000946663,0.00012581398,0.00006771395,3.8388353e-7,0.00022774725,0.00010417296,0.98147374,0.000040650084,0.00057831884,0.015224772],"study_design_scores_gemma":[0.007969687,0.000052197905,0.00079397083,0.00005021442,0.00013113293,0.000032536653,0.00008271431,0.004542425,0.8232481,0.000041741354,0.16273822,0.0003170776],"about_ca_topic_score_codex":0.00004953174,"about_ca_topic_score_gemma":0.000009664358,"teacher_disagreement_score":0.17803112,"about_ca_system_score_codex":0.00005496478,"about_ca_system_score_gemma":0.00016651988,"threshold_uncertainty_score":0.9999786},"labels":[],"label_agreement":null},{"id":"W2021997973","doi":"10.1089/cbr.2007.0430","title":"<i>Update:</i> Peptide Motifs for Insertion of Radiolabeled Biomolecules into Cells and Routing to the Nucleus for Cancer Imaging or Radiotherapeutic Applications","year":2008,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cytoplasm; Cancer cell; Nucleus; Internalization; Chemistry; Peptide; Cell biology; Intracellular; Cell; Biophysics; Biochemistry; Cancer; Biology; Genetics","score_opus":0.06785277283146808,"score_gpt":0.4421922385253275,"score_spread":0.37433946569385945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021997973","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025836568,0.9725184,0.014473924,0.00367803,0.00014108958,0.0077346438,0.0011126604,0.000070101334,0.0000127816775],"genre_scores_gemma":[0.00058836694,0.9820207,0.0046723047,0.0029409428,0.0009572401,0.008392616,0.000075166,0.00014993493,0.00020275674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973575,0.00008825863,0.00093186006,0.0008719358,0.0002014824,0.0005490016],"domain_scores_gemma":[0.9978861,0.0006144764,0.00037426042,0.00047432192,0.00017895023,0.0004718612],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002654316,0.00061950076,0.0016275786,0.00014739178,0.0005045837,0.000061078885,0.00031702465,0.00027878702,0.000042175347],"category_scores_gemma":[0.00003325658,0.000404243,0.00041987005,0.0006047055,0.0005147081,0.00007609022,0.000042256794,0.0003547541,0.0000018537205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005781029,0.00014546672,0.00001456768,0.013245129,0.0007694293,0.0000025878767,0.00022555036,0.000006551527,0.04607624,0.0002623533,0.0010886262,0.9375854],"study_design_scores_gemma":[0.002113619,0.00009037267,0.00000205927,0.002291351,0.0018293441,0.00017044062,0.000028888966,0.0015905193,0.021263158,0.000024893327,0.97013676,0.00045856947],"about_ca_topic_score_codex":0.00002248461,"about_ca_topic_score_gemma":0.0000035971314,"teacher_disagreement_score":0.96904814,"about_ca_system_score_codex":0.00024931625,"about_ca_system_score_gemma":0.00047886482,"threshold_uncertainty_score":0.9998409},"labels":[],"label_agreement":null},{"id":"W2022046169","doi":"10.1089/cbr.2006.21.613","title":"Human Dendritic Cells Engineered to Express Alpha Tumor Necrosis Factor Maintain Cellular Maturation and T-Cell Stimulation Capacity","year":2006,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Tumor necrosis factor alpha; Ex vivo; Immunology; Dendritic cell; Immune system; Cytokine; Peripheral blood mononuclear cell; Biology; Granulocyte macrophage colony-stimulating factor; In vivo; Cancer research; Medicine; In vitro","score_opus":0.018775526164473415,"score_gpt":0.28255336468414033,"score_spread":0.2637778385196669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022046169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96599877,0.030727908,0.0015773674,0.00029620255,0.0005130114,0.00062877225,0.0001408419,0.000084837004,0.000032283606],"genre_scores_gemma":[0.99614984,0.0013107925,0.00028080615,0.0007773921,0.00010965808,0.00007414907,0.000029632945,0.000041608535,0.0012261452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984265,0.00026160618,0.00037773926,0.00041721022,0.000057697875,0.00045927876],"domain_scores_gemma":[0.9994567,0.0001327323,0.00008861212,0.000204158,0.000052191022,0.00006559209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018162417,0.00031942187,0.00037296716,0.00015788284,0.00037701108,0.00008416161,0.00012893848,0.00022597781,0.00070221984],"category_scores_gemma":[0.0000064890346,0.0002886109,0.00007515318,0.00014347759,0.00025108652,0.00017282096,0.00002522774,0.00025802158,0.000022430422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060899864,0.00011789697,0.0002916662,0.00006773352,0.00008358438,0.00000382306,0.00038703668,0.000059959075,0.9956225,0.00034335797,0.00039351187,0.0020199053],"study_design_scores_gemma":[0.0028757083,0.00017907117,0.006927026,0.000053081985,0.00004526921,0.00001546618,0.000041991636,0.00008156897,0.9612114,0.00008213156,0.028115433,0.00037186118],"about_ca_topic_score_codex":0.0002479302,"about_ca_topic_score_gemma":0.000005318949,"teacher_disagreement_score":0.034411136,"about_ca_system_score_codex":0.00008168825,"about_ca_system_score_gemma":0.000029475994,"threshold_uncertainty_score":0.9999566},"labels":[],"label_agreement":null},{"id":"W2022046439","doi":"10.1089/cbr.2009.0714","title":"Tumor Necrosis Factor Gene-Engineered J558 Tumor Cell–Released Exosomes Stimulate Tumor Antigen P1A-Specific CD8 <sup>+</sup> CTL Responses and Antitumor Immunity","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"CTL*; Cytotoxic T cell; CD8; Tumor antigen; Molecular biology; Immune system; Antigen; Tumor necrosis factor alpha; Biology; T cell; Immunology; Immunotherapy; Biochemistry","score_opus":0.018511428718595187,"score_gpt":0.30249453200982324,"score_spread":0.28398310329122806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022046439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.947763,0.049738444,0.00020354768,0.00032627015,0.00037565746,0.00072345947,0.0007495718,0.00008503347,0.000035006266],"genre_scores_gemma":[0.97693175,0.018684234,0.0014971761,0.0016230153,0.00061640167,0.0000845232,0.000059327227,0.00013335377,0.0003701973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997145,0.00027211086,0.0005416039,0.0009813063,0.00027527282,0.0007847133],"domain_scores_gemma":[0.99803454,0.00012963584,0.00018189741,0.00080253434,0.00012929362,0.0007220931],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036286982,0.0006289502,0.0005682721,0.00015769179,0.00040456737,0.00019927358,0.00046221673,0.0002188496,0.0004708866],"category_scores_gemma":[0.00008430197,0.0005825775,0.00021004924,0.00023091376,0.0008576428,0.000039072293,0.00014229228,0.00057132816,0.000012006237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015476637,0.0002269735,0.0072804964,0.00014339043,0.00016515433,0.000112226284,0.00016026759,0.00006398268,0.987286,0.000031041072,0.00053509965,0.0024477423],"study_design_scores_gemma":[0.0035124486,0.00022141835,0.012915961,0.000043298478,0.00006920273,0.000109964894,0.00005599889,0.0015860253,0.91596025,0.00003143997,0.06469924,0.00079476135],"about_ca_topic_score_codex":0.000034786994,"about_ca_topic_score_gemma":0.0000035447608,"teacher_disagreement_score":0.07132572,"about_ca_system_score_codex":0.00003664762,"about_ca_system_score_gemma":0.00024054656,"threshold_uncertainty_score":0.9996626},"labels":[],"label_agreement":null},{"id":"W2024836545","doi":"10.1089/1084978041424990","title":"Engineered Fusion Hybrid Vaccine of IL-18 Gene-Modified Tumor Cells and Dendritic Cells Induces Enhanced Antitumor Immunity","year":2004,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"CTL*; Immunotherapy; Immune system; Antigen; Dendritic cell; Immunology; Cell fusion; Immunization; Biology; Interleukin 12; Cytotoxic T cell; Cell culture; In vitro; CD8","score_opus":0.02081627550124255,"score_gpt":0.3005928175866874,"score_spread":0.27977654208544483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024836545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8815799,0.11604481,0.00037936596,0.00025321185,0.0009274869,0.00048094353,0.00023910528,0.0000613313,0.00003387379],"genre_scores_gemma":[0.9205903,0.078284405,0.00017529567,0.0005904989,0.000060457878,0.00003942014,0.000020135334,0.00004177581,0.00019770951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812156,0.0002701203,0.00056598336,0.00043856786,0.000069200345,0.00053455424],"domain_scores_gemma":[0.9990957,0.00021679714,0.00018940134,0.00033205794,0.000088883055,0.00007720607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034404034,0.00039951404,0.0007083628,0.00020932006,0.00029995237,0.000031621537,0.0002556565,0.00020368205,0.0005563896],"category_scores_gemma":[0.000016297958,0.00033950014,0.00012242422,0.00021107003,0.0004854065,0.00017654405,0.000060791204,0.0004370417,0.000013852873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002165712,0.00022842456,0.00002312258,0.00013022026,0.0003806252,0.000012568901,0.0005263595,0.000046360954,0.9873964,0.00013534361,0.00006201628,0.008892814],"study_design_scores_gemma":[0.00779094,0.00040507913,0.0010704236,0.00017444835,0.000092030976,0.000117946656,0.00009597178,0.000009931572,0.98285395,0.00006816378,0.0069232304,0.00039787567],"about_ca_topic_score_codex":0.00012868037,"about_ca_topic_score_gemma":0.0000016558665,"teacher_disagreement_score":0.039010428,"about_ca_system_score_codex":0.00006055749,"about_ca_system_score_gemma":0.00014281305,"threshold_uncertainty_score":0.9999057},"labels":[],"label_agreement":null},{"id":"W2027381742","doi":"10.1089/cbr.2010.0793","title":"Radiotracers for Noninvasive Molecular Imaging of Tumor Cell Death","year":2010,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Killam Trusts; Cancer Research Institute","keywords":"Programmed cell death; Autophagy; Apoptosis; Medicine; Mechanism (biology); Clinical trial; Cancer; Molecular imaging; Cancer research; Cell; Neuroscience; Bioinformatics; Pathology; Biology; In vivo; Internal medicine","score_opus":0.03000672279274699,"score_gpt":0.37455548626592566,"score_spread":0.3445487634731787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027381742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006081445,0.99431515,0.0029894772,0.000041919102,0.0004764945,0.0012454415,0.00023522877,0.0000105040235,0.00007763753],"genre_scores_gemma":[0.0002912729,0.9964077,0.0018979576,0.00028326488,0.00048203112,0.00022011391,0.0001229719,0.00010033736,0.0001943542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846494,0.000072029165,0.0004440021,0.00057864067,0.000112785776,0.00032758206],"domain_scores_gemma":[0.99907196,0.000044774428,0.0003242695,0.00030884024,0.00008242112,0.00016771336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021890026,0.00041845546,0.0008904329,0.000098144716,0.00008400549,0.000027225286,0.0002044177,0.00037642012,0.000043246782],"category_scores_gemma":[0.000011129267,0.00033630693,0.00048036125,0.00008913126,0.00016135417,0.0000047590556,0.00003612395,0.00022046873,6.234526e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006288629,0.00004677444,0.0000057436864,0.0054435865,0.00020376669,0.000007414789,0.000016844442,0.0000051408483,0.28900662,0.0002544047,0.00013232049,0.7048145],"study_design_scores_gemma":[0.0007865556,0.00008770537,6.650968e-7,0.0006343669,0.00048315665,0.000050884115,0.0000042682414,0.00006183174,0.13919145,0.000026791406,0.8583113,0.00036102172],"about_ca_topic_score_codex":0.0000048735355,"about_ca_topic_score_gemma":7.4503566e-7,"teacher_disagreement_score":0.858179,"about_ca_system_score_codex":0.000028572666,"about_ca_system_score_gemma":0.00028424538,"threshold_uncertainty_score":0.9999089},"labels":[],"label_agreement":null},{"id":"W2029424531","doi":"10.1089/cbr.2012.1196","title":"Positron-Emission Tomography Imaging of the TSPO with [ <sup>18</sup> F]FEPPA in a Preclinical Breast Cancer Model","year":2013,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Translocator protein; Biodistribution; Radiosynthesis; Positron emission tomography; Ex vivo; In vivo; Preclinical imaging; Nuclear medicine; Breast cancer; Molecular imaging; Imaging agent; Chemistry; Medicine; Radioligand; Cancer research; Cancer; Pathology; Receptor; Internal medicine; Biology; Neuroinflammation","score_opus":0.029773001461898912,"score_gpt":0.3653497138057176,"score_spread":0.3355767123438187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029424531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584043,0.025653912,0.00002233223,0.014582765,0.00005148182,0.0010544271,0.00006331275,0.000022106784,0.0001453892],"genre_scores_gemma":[0.9849175,0.011789746,0.00026722325,0.0024841118,0.0000989535,0.0003526076,0.0000019176325,0.000030639098,0.000057251447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866015,0.00006669194,0.0003331123,0.00036860583,0.00023798615,0.0003334268],"domain_scores_gemma":[0.9992342,0.0000812029,0.00009290301,0.00026100036,0.00008447615,0.00024620994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000129413,0.00023283112,0.00043093288,0.00010910594,0.000075067685,0.000024043446,0.00010767954,0.000091580216,0.0005735953],"category_scores_gemma":[0.000004686074,0.0001232706,0.00013398593,0.00034736452,0.00030953533,0.00011033646,0.000026960854,0.00023595933,0.0000010203768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009377704,0.0006400115,0.8926385,0.00014668415,0.00031041412,0.000013226597,0.00045290898,0.00093083415,0.056341562,0.00004769726,0.0009162655,0.04662415],"study_design_scores_gemma":[0.019867858,0.00027187512,0.7041972,0.0025527761,0.00065101706,0.00020588575,0.00015995832,0.16980411,0.099341534,0.00020096937,0.0021911496,0.0005556656],"about_ca_topic_score_codex":0.00043501056,"about_ca_topic_score_gemma":0.0000075194284,"teacher_disagreement_score":0.18844128,"about_ca_system_score_codex":0.000093339084,"about_ca_system_score_gemma":0.00015100649,"threshold_uncertainty_score":0.6280466},"labels":[],"label_agreement":null},{"id":"W2032007643","doi":"10.1089/cbr.2008.0582","title":"Adenovirus-Mediated ING4 Expression Suppresses Pancreatic Carcinoma Cell Growth via Induction of Cell-Cycle Alteration, Apoptosis, and Inhibition of Tumor Angiogenesis","year":2009,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; Transfection; Genetic enhancement; Biology; Cell cycle; Angiogenesis; Tumor suppressor gene; Cell growth; Apoptosis; Pancreatic tumor; Viral vector; Growth inhibition; Pancreatic cancer; Cell culture; Carcinogenesis; Cancer; Gene; Recombinant DNA","score_opus":0.012488129391987913,"score_gpt":0.29454405836041986,"score_spread":0.28205592896843196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032007643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752569,0.023918856,0.00023283628,0.00013831045,0.000042724267,0.00027574901,0.00009830185,0.000006467534,0.000029848108],"genre_scores_gemma":[0.97497755,0.024414642,0.00016971251,0.00019308129,0.00012757666,0.00003231012,0.00006157098,0.00001334224,0.000010213478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912107,0.000082595325,0.00022349364,0.00027094426,0.00012554896,0.00017635513],"domain_scores_gemma":[0.9995384,0.00001949073,0.00011112251,0.000117830044,0.000089661866,0.0001234725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008495594,0.00014742614,0.00020404333,0.000076557924,0.00007280861,0.000014212409,0.000048815735,0.00008794616,0.000035942296],"category_scores_gemma":[0.000009565956,0.00012589952,0.00004924633,0.00011864653,0.00013343441,0.000019331532,0.000018402427,0.000050456576,2.6740778e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056360115,0.00016689699,0.007709553,0.00014152557,0.000038410428,0.0000013970301,0.00012460041,0.0000063811785,0.98927945,0.0000028435572,0.0001520442,0.0018132927],"study_design_scores_gemma":[0.0020704265,0.00048813928,0.006207071,0.00004150729,0.000038519105,0.0000048554725,0.000027394522,0.00007056001,0.99065804,0.000034475237,0.00023697776,0.000122020945],"about_ca_topic_score_codex":0.00010126899,"about_ca_topic_score_gemma":0.0000024818203,"teacher_disagreement_score":0.0016912718,"about_ca_system_score_codex":0.000019413417,"about_ca_system_score_gemma":0.00005475764,"threshold_uncertainty_score":0.5134033},"labels":[],"label_agreement":null},{"id":"W2034006621","doi":"10.1089/cbr.2005.20.379","title":"Pretargeted Radioimmunotherapy (RIT) with a Novel Anti-TAG-72 Fusion Protein","year":2005,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Radioimmunotherapy; DOTA; Medicine; Nuclear medicine; Pretargeting; Dosimetry; Pharmacology; Chemistry; Antibody; Immunology; Chelation; Monoclonal antibody","score_opus":0.028959659007428747,"score_gpt":0.34908118884797795,"score_spread":0.3201215298405492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034006621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94003195,0.03755118,0.001910352,0.017335774,0.000061825136,0.0018339237,0.00009184053,0.00024588496,0.00093726406],"genre_scores_gemma":[0.96915007,0.015975246,0.00538403,0.006370217,0.000883766,0.00046700734,0.000022802056,0.00008729829,0.0016595641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795675,0.000039010105,0.0004129668,0.0006413272,0.00033239258,0.0006175567],"domain_scores_gemma":[0.99879605,0.00005826187,0.00010884174,0.00039954836,0.000101004654,0.00053631543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002341541,0.00040545067,0.00056306965,0.00008596922,0.00028697698,0.000057392717,0.0001488643,0.00022291532,0.0013508472],"category_scores_gemma":[0.000009730842,0.00029795864,0.0001221752,0.00042411636,0.00049819675,0.00018479659,0.000020253268,0.0005155392,0.000012756575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014140357,0.00051706756,0.0012073604,0.00018841677,0.00032623345,0.000015377716,0.0001706728,0.000029848392,0.95307577,0.00046362696,0.00024328943,0.042348307],"study_design_scores_gemma":[0.0084395865,0.0002004577,0.0019994827,0.00023308369,0.00016426356,0.00028538395,0.000021118925,0.0031834224,0.63007355,0.000013420674,0.35497192,0.0004143419],"about_ca_topic_score_codex":0.000009981192,"about_ca_topic_score_gemma":7.340751e-7,"teacher_disagreement_score":0.3547286,"about_ca_system_score_codex":0.000138349,"about_ca_system_score_gemma":0.00017101104,"threshold_uncertainty_score":0.99994725},"labels":[],"label_agreement":null},{"id":"W2039880390","doi":"10.1089/cbr.2006.21.74","title":"Conversion of Tolerogenic CD4¯8¯ Dendritic Cells to Immunogenic Ones Inducing Efficient Antitumor Immunity","year":2006,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Immune system; Dendritic cell; Ovalbumin; CTL*; Immunology; Antigen; Immunotherapy; Cytotoxic T cell; Biology; Immune tolerance; Immunity; Chemistry; Cell biology; CD8; In vitro; Biochemistry","score_opus":0.01673550027278966,"score_gpt":0.29668439818972897,"score_spread":0.27994889791693933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039880390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8418752,0.15602264,0.00013576326,0.00026937737,0.0010322413,0.00046885828,0.000071549235,0.00005443853,0.000069911315],"genre_scores_gemma":[0.98786277,0.010599449,0.00008362907,0.0005861367,0.000060278162,0.000038792827,0.000015224982,0.000038645267,0.00071508606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979805,0.00038795895,0.00058283313,0.00039907655,0.000081146725,0.00056851597],"domain_scores_gemma":[0.9990597,0.00024963808,0.00016167203,0.00037610898,0.0001001053,0.000052786774],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044008813,0.00032862608,0.0005816063,0.0002474395,0.00035379437,0.000027405724,0.00030857115,0.00026011927,0.0011604936],"category_scores_gemma":[0.000014166936,0.00028824716,0.00018961917,0.00036484783,0.00053920987,0.00008418937,0.00007291152,0.00033369847,0.000075642245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017444126,0.0002672824,0.0006098465,0.00009522843,0.0003147654,0.000004751041,0.00040833835,0.00014110639,0.9913533,0.0002052588,0.00026776755,0.0045879805],"study_design_scores_gemma":[0.0030889146,0.00025114234,0.0054477304,0.0001563104,0.00008447976,0.00005707371,0.0001352569,0.000029628092,0.9541982,0.0000096797685,0.03620017,0.00034143825],"about_ca_topic_score_codex":0.00055194844,"about_ca_topic_score_gemma":0.0000034896525,"teacher_disagreement_score":0.14598754,"about_ca_system_score_codex":0.00009280937,"about_ca_system_score_gemma":0.00012690361,"threshold_uncertainty_score":0.99995697},"labels":[],"label_agreement":null},{"id":"W2045316963","doi":"10.1089/108497804773391757","title":"Molecular Imaging and Treatment of Malignant Gliomas Following Adenoviral Transfer of the Herpes Simplex Virus-Thymidine Kinase Gene and the Somatostatin Receptor Subtype 2 Gene","year":2004,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Somatostatin receptor; Genetic enhancement; Herpes simplex virus; Multiplicity of infection; Somatostatin receptor 2; Glioma; Somatostatin; Thymidine kinase; Cancer research; Cell culture; Radionuclide therapy; In vivo; Biology; Molecular biology; Virology; Medicine; Virus; Internal medicine; Endocrinology; Gene; Biochemistry","score_opus":0.01796847720985809,"score_gpt":0.32318984023961256,"score_spread":0.30522136302975444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045316963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86722803,0.13001333,0.00017398616,0.0018532122,0.000067571586,0.00054577703,0.0001073804,0.000005450348,0.0000052601595],"genre_scores_gemma":[0.9370244,0.06205888,0.00014858259,0.0005737098,0.00008335031,0.00005410931,0.0000081534345,0.00003504697,0.000013781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867576,0.0002038832,0.00029135862,0.00035499292,0.00018180325,0.00029217618],"domain_scores_gemma":[0.9994653,0.000035918543,0.00006256759,0.00027769178,0.000044409597,0.000114116134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026689807,0.00023863855,0.00033090162,0.000046188215,0.00014132133,0.000024280409,0.00014901775,0.00008695144,0.000022554867],"category_scores_gemma":[0.000009892966,0.00013994197,0.00015052946,0.00015470722,0.0007614631,0.000008774112,0.00003695691,0.000061019105,1.6609641e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003647487,0.00009162102,0.0005308196,0.00003572434,0.0003817371,0.000007741615,0.00044353632,0.000051492734,0.9597226,0.00009836746,0.000005863782,0.03498303],"study_design_scores_gemma":[0.007972076,0.00063328847,0.00031203663,0.00003366207,0.00009139535,0.000016436732,0.00005930596,0.00006821215,0.98727536,0.00007159664,0.0033024398,0.00016416484],"about_ca_topic_score_codex":0.00011973558,"about_ca_topic_score_gemma":0.000032183438,"teacher_disagreement_score":0.06979636,"about_ca_system_score_codex":0.0000303652,"about_ca_system_score_gemma":0.00012393703,"threshold_uncertainty_score":0.5706668},"labels":[],"label_agreement":null},{"id":"W2046217321","doi":"10.1089/cbr.2005.20.290","title":"Molecular and Immunophenotypical Characterization of Progressive and Regressive Leukemia Cell Lines","year":2005,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Biology; Cell culture; Cancer research; Mastocytoma; Immunophenotyping; Molecular biology; Tumor progression; Fibrosarcoma; Gene; Immunology; Flow cytometry; Tumor cells; Genetics","score_opus":0.011398879246882761,"score_gpt":0.2956756507662672,"score_spread":0.2842767715193844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046217321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7268867,0.27182573,0.000062998355,0.00075840787,0.00012746011,0.00025665615,0.00003385115,0.000022004877,0.000026184076],"genre_scores_gemma":[0.9258428,0.0727585,0.00011592106,0.00078506465,0.000060968243,0.00004215125,0.000017214437,0.000024573372,0.00035278566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988765,0.00019771775,0.00031784945,0.00030156306,0.000038102222,0.00026827992],"domain_scores_gemma":[0.99947643,0.00010260519,0.00016809785,0.00014998995,0.0000625844,0.000040311897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000144046,0.00022847304,0.00037393929,0.000091455084,0.0001540602,0.000024783469,0.00009316335,0.00025120925,0.0002501714],"category_scores_gemma":[0.000012791129,0.00018201506,0.000046263787,0.00009642786,0.0007878926,0.00015548465,0.000039509494,0.0002234316,0.0000032752582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015571982,0.000057207017,0.00044122792,0.00007029517,0.00018486647,0.0000030217045,0.000657792,0.00000117759,0.88174444,0.00030345272,0.000016073967,0.11496324],"study_design_scores_gemma":[0.003091981,0.00019901303,0.0055487705,0.000105534185,0.00006153491,0.000067292785,0.000050368475,0.000045105804,0.9522489,0.000019619461,0.038342867,0.00021901929],"about_ca_topic_score_codex":0.000010198293,"about_ca_topic_score_gemma":2.6200803e-7,"teacher_disagreement_score":0.19906723,"about_ca_system_score_codex":0.000031590764,"about_ca_system_score_gemma":0.00007220302,"threshold_uncertainty_score":0.7422359},"labels":[],"label_agreement":null},{"id":"W2051614202","doi":"10.1089/cbr.2010.0806","title":"A Case of Rituximab-Induced Hepatitis","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Rituximab; Medicine; Hepatitis; Etiology; Immunology; Hepatitis C; Virology; Internal medicine; Lymphoma","score_opus":0.034307700647676305,"score_gpt":0.38102177134243403,"score_spread":0.34671407069475774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051614202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304706,0.0048294454,0.0000109241855,0.00096298795,0.00023952831,0.0002900402,0.000042623295,0.000024943927,0.0005524725],"genre_scores_gemma":[0.98888874,0.009499291,0.00040440127,0.00096629263,0.00010159088,0.000026569982,0.0000028131408,0.000016586864,0.00009371508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938965,0.0000145955955,0.00016308742,0.000183562,0.000074955744,0.00017413587],"domain_scores_gemma":[0.99955416,0.000036506797,0.000042980108,0.00013811895,0.000040249983,0.00018797263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068684916,0.00012229102,0.00033237023,0.000057639856,0.000057494355,0.000008265418,0.000028693436,0.0001052601,0.0007618482],"category_scores_gemma":[0.000008850355,0.00009186345,0.00006260036,0.00010553767,0.00013464117,0.000047266243,0.000007156116,0.00018001259,0.000004264923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046921585,0.0006179366,0.027223645,0.00015457254,0.00042813914,0.0052910745,0.00034767418,1.0504133e-7,0.69635564,0.0006549824,0.00017064344,0.26828635],"study_design_scores_gemma":[0.03691345,0.0010929428,0.01605378,0.00018552504,0.00072652247,0.030258887,0.0000853618,0.001432516,0.8535718,0.000500114,0.05854268,0.0006364319],"about_ca_topic_score_codex":0.00030509563,"about_ca_topic_score_gemma":0.00005537102,"teacher_disagreement_score":0.26764992,"about_ca_system_score_codex":0.000013068222,"about_ca_system_score_gemma":0.000057071225,"threshold_uncertainty_score":0.83417034},"labels":[],"label_agreement":null},{"id":"W2059472076","doi":"10.1089/cbr.2004.19.669","title":"The Immunoreactivity of Radiolabeled Antibodies—Its Impact on Tumor Targeting and Strategies for Preservation","year":2004,"lang":"en","type":"editorial","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Radioimmunotherapy; Trastuzumab; Monoclonal antibody; Cancer research; Breast cancer; Cancer; Medicine; Antibody; Molecular imaging; In vivo; Internal medicine; Biology; Immunology","score_opus":0.026490259766567915,"score_gpt":0.4283959741969743,"score_spread":0.40190571443040635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059472076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5216684,0.3625492,0.00043615839,0.0052919327,0.09826848,0.0071705086,0.0037488798,0.00021555906,0.00065091136],"genre_scores_gemma":[0.47707418,0.25170073,0.0003493296,0.0004990046,0.2683281,0.0010140167,0.00035261063,0.00018735958,0.0004946498],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980561,0.000069045054,0.0005232882,0.0005368705,0.00037024557,0.0004444301],"domain_scores_gemma":[0.9970013,0.0018334981,0.00032765142,0.00029165501,0.00029318078,0.0002527108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005964646,0.00045302327,0.0007889455,0.000055800396,0.00039304787,0.000108198634,0.00017715189,0.00042536284,0.000033185785],"category_scores_gemma":[0.00027015377,0.0002839315,0.00021032125,0.00016828772,0.0005406431,0.0001754332,0.000025062003,0.0008152928,4.897986e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011296887,0.00044532897,0.00017932274,0.0044202497,0.00203042,0.000009883322,0.00031208765,0.00009459004,0.8278478,0.0022722636,0.13997023,0.011120969],"study_design_scores_gemma":[0.0071957163,0.00066035613,0.00028543535,0.00079228764,0.0006545866,0.000014812036,0.00007570375,0.0014070091,0.18867968,0.0007362289,0.7989878,0.0005103665],"about_ca_topic_score_codex":0.00003345568,"about_ca_topic_score_gemma":7.315532e-7,"teacher_disagreement_score":0.65901756,"about_ca_system_score_codex":0.00021469468,"about_ca_system_score_gemma":0.0008224275,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W2067326341","doi":"10.1089/cbr.2012.1200.271","title":"Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential","year":2012,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Immunotoxin; Epithelial cell adhesion molecule; Pharmacology; Medicine; Immunotherapy; Adverse effect; Pharmacokinetics; Antibody; Immunology; Monoclonal antibody; Immune system","score_opus":0.06114198218091945,"score_gpt":0.3889204511167967,"score_spread":0.32777846893587725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067326341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86463857,0.13270466,0.00026406813,0.00012545953,0.0013645167,0.0007062753,0.000061942985,0.000048294143,0.00008619542],"genre_scores_gemma":[0.99195063,0.0069671525,0.00028284537,0.00020423887,0.00018828137,0.00011501292,0.000041132615,0.000046329937,0.00020435703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997599,0.00069614686,0.0005365404,0.00040565434,0.00014465505,0.0006179868],"domain_scores_gemma":[0.99896294,0.00007713633,0.00023810561,0.00043594665,0.00017702526,0.00010886452],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015720753,0.00031441622,0.0005236689,0.00010527783,0.0002740264,0.000029229725,0.00025941664,0.00039469762,0.004024379],"category_scores_gemma":[0.000029126413,0.00023863111,0.00012705947,0.00018128289,0.00073325966,0.0004065067,0.000033661312,0.00039199396,0.00002497679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093224493,0.00037824066,0.0020719336,0.000027099579,0.0006090799,6.2135103e-7,0.0007554887,0.00002951304,0.952873,0.00039975814,0.000041826228,0.041881207],"study_design_scores_gemma":[0.0075291116,0.00061919866,0.03171503,0.00008625112,0.0005331931,0.00009730752,0.00024221888,0.00017686095,0.95225364,0.000049118502,0.00627521,0.00042284656],"about_ca_topic_score_codex":0.000031808733,"about_ca_topic_score_gemma":0.0000013356339,"teacher_disagreement_score":0.12731205,"about_ca_system_score_codex":0.00005691775,"about_ca_system_score_gemma":0.00024041889,"threshold_uncertainty_score":0.9968861},"labels":[],"label_agreement":null},{"id":"W2068717865","doi":"10.1089/cbr.2010.0778","title":"Tumor-Suppressive Effect of Adenovirus-Mediated Inhibitor of Growth 4 Gene Transfer in Breast Carcinoma Cells <i>In Vitro</i> and <i>In Vivo</i>","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; Breast carcinoma; Biology; Apoptosis; Downregulation and upregulation; Tumor suppressor gene; In vivo; Nude mouse; Breast cancer; Cancer; Carcinogenesis; Gene","score_opus":0.006494608147965627,"score_gpt":0.2650902706782928,"score_spread":0.2585956625303272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068717865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819114,0.015894853,0.000008405032,0.00038931041,0.0002764921,0.0010038259,0.0004391375,0.000013669467,0.000062861705],"genre_scores_gemma":[0.9925294,0.0065988284,0.00006564953,0.0005615159,0.000103011334,0.000078933306,0.000006635099,0.00004843868,0.0000075993776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982056,0.0001532629,0.00056775374,0.00045053827,0.00023006219,0.00039279307],"domain_scores_gemma":[0.99926794,0.00017050625,0.00007831873,0.00019942867,0.000050497736,0.00023331115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036548238,0.00030080933,0.0008631566,0.00033714095,0.000017765371,0.000007304261,0.00009258931,0.0002605213,0.00008597078],"category_scores_gemma":[0.000015288218,0.00025524633,0.000094224335,0.0004990772,0.00045386367,0.00007703667,0.000018456232,0.00064264674,5.4285675e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070883976,0.00033694968,0.017540094,0.0005769374,0.000047502894,0.00017579136,0.00040727443,0.0000034769562,0.971679,0.000007753366,0.000028508388,0.0021083208],"study_design_scores_gemma":[0.025973808,0.00026958084,0.005567143,0.0002922028,0.00007679258,0.00015581917,0.00001366256,0.00034454203,0.9666523,0.000003514547,0.0004334424,0.00021724512],"about_ca_topic_score_codex":0.00026497955,"about_ca_topic_score_gemma":0.0000518824,"teacher_disagreement_score":0.01888541,"about_ca_system_score_codex":0.00007572591,"about_ca_system_score_gemma":0.0001548427,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W2068889233","doi":"10.1089/cbr.2006.21.225","title":"Oncolytic Adenovirus-Mediated E1A Gene Therapy Induces Tumor-Cell Apoptosis and Reduces Tumor Angiogenesis Leading to Inhibition of Hepatocellular Carcinoma Growth in Animal Model","year":2006,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Oncolytic virus; Cancer research; Survivin; Angiogenesis; Oncolytic adenovirus; Genetic enhancement; Downregulation and upregulation; Apoptosis; Hepatocellular carcinoma; Adenoviridae; Biology; Gene","score_opus":0.03281651847950419,"score_gpt":0.3200040272150378,"score_spread":0.2871875087355336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068889233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606509,0.037991278,0.000041521973,0.00037164555,0.000050245384,0.00070739596,0.00012311724,0.000016470745,0.000047429632],"genre_scores_gemma":[0.9864727,0.011722283,0.00025544668,0.0009744742,0.00027602166,0.00015766079,0.00003193881,0.00006655753,0.0000428923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979439,0.00016911853,0.00044924484,0.00066766207,0.00025670396,0.0005134204],"domain_scores_gemma":[0.9993009,0.000038873965,0.000122026904,0.00020012628,0.000107381784,0.00023067859],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040057598,0.0003389995,0.00043222125,0.00028767146,0.00010659764,0.000041698848,0.00017311383,0.00016545231,0.000027164328],"category_scores_gemma":[0.000012293017,0.00031921067,0.000094796495,0.0004367343,0.0002719608,0.00002183966,0.000055658864,0.00015319927,0.0000017165759],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045126784,0.00019319104,0.0072821537,0.00007029001,0.00005729279,0.000010415192,0.0001524399,0.00018717155,0.9862677,0.00000878976,0.000097133234,0.0011607336],"study_design_scores_gemma":[0.0027508857,0.0013332032,0.0011046939,0.000040825722,0.00002048652,0.000008624854,0.00004295812,0.0016694854,0.99243665,0.00003176831,0.00018486146,0.00037556488],"about_ca_topic_score_codex":0.00016185358,"about_ca_topic_score_gemma":0.000014628952,"teacher_disagreement_score":0.026268994,"about_ca_system_score_codex":0.00007560915,"about_ca_system_score_gemma":0.00021102026,"threshold_uncertainty_score":0.999926},"labels":[],"label_agreement":null},{"id":"W2070785431","doi":"10.1089/cbr.2009.0713","title":"Antiproliferative Effects of <sup>111</sup> In- or <sup>177</sup> Lu-DOTATOC on Cells Exposed to Low Multiplicity-of-Infection Double-Deleted Vaccinia Virus Encoding Somatostatin Subtype-2 Receptor","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Bystander effect; Oncolytic virus; Multiplicity of infection; Cancer research; Vaccinia; Somatostatin receptor; Virus; Transfection; Medicine; Immune system; HEK 293 cells; Virology; Genetic enhancement; Cell culture; Biology; Receptor; Immunology; Internal medicine; Gene","score_opus":0.023050070907374366,"score_gpt":0.3488757189056654,"score_spread":0.325825647998291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070785431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961819,0.00126892,0.000170359,0.00021379026,0.00019634448,0.0017959218,0.00011014092,0.000028339968,0.000034258173],"genre_scores_gemma":[0.98996156,0.008068229,0.0003899613,0.0008320667,0.00031244065,0.00024867876,0.000024288613,0.00008333594,0.000079449084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99742186,0.00032440238,0.0005866126,0.00075177336,0.00031269016,0.0006026882],"domain_scores_gemma":[0.9985919,0.00024612303,0.00018451242,0.0004532052,0.0001821739,0.00034209067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005257776,0.00043642306,0.00061831326,0.00029172678,0.00013228408,0.00003879978,0.00026021936,0.00037486973,0.0002540096],"category_scores_gemma":[0.00008189123,0.00036550165,0.0001480746,0.00050501624,0.00022897121,0.000023042068,0.00006358905,0.00048331515,0.000010147488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028335724,0.00040267297,0.0025808797,0.00033548233,0.00023596636,0.000009252138,0.0010023117,0.0013152591,0.95139503,0.00001942537,0.00015125408,0.014216756],"study_design_scores_gemma":[0.007929492,0.0039260727,0.00031688006,0.00017362571,0.000025671432,0.0000053146873,0.000055076147,0.003460371,0.9819456,0.0000052832966,0.0017513521,0.00040528888],"about_ca_topic_score_codex":0.00009459751,"about_ca_topic_score_gemma":0.000101314654,"teacher_disagreement_score":0.030550556,"about_ca_system_score_codex":0.000060185354,"about_ca_system_score_gemma":0.0002586173,"threshold_uncertainty_score":0.9998797},"labels":[],"label_agreement":null},{"id":"W2074270333","doi":"10.1089/cbr.2010.0813","title":"<i>In Vitro</i> Characterization of Two Novel Biodegradable Vectors for the Delivery of Radiolabeled Antisense Oligonucleotides","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"Austrian Science Fund; Alberta Cancer Foundation","keywords":"Oligonucleotide; In vivo; In vitro; Chemistry; Intracellular; Biochemistry; Molecular biology; Biophysics; Biology; DNA","score_opus":0.018293639654973097,"score_gpt":0.3209996154214861,"score_spread":0.302705975766513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074270333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341,0.0047783297,0.0005529065,0.00031589795,0.00039682587,0.00031974705,0.00021579176,0.000003269715,0.000007241829],"genre_scores_gemma":[0.98289615,0.015761388,0.00037639795,0.00063148147,0.00020907201,0.000034495297,0.000020614558,0.000015952694,0.00005442203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929035,0.000022040656,0.00024592085,0.00021005966,0.000060951865,0.00017069698],"domain_scores_gemma":[0.9995501,0.000047266058,0.00010811882,0.00017284593,0.000082926235,0.000038753424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018235373,0.00012532299,0.00020721433,0.000047245125,0.00004541769,0.000010016422,0.00013604277,0.00009572481,0.000033365275],"category_scores_gemma":[0.000011506692,0.000090267065,0.00007967639,0.0000967826,0.00022084778,0.000011178742,0.000017612643,0.00008467024,2.2480539e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007579631,0.00006508598,0.00094359805,0.00004303278,0.00009677821,2.9782242e-7,0.00005144191,0.0000067745345,0.9893821,0.00008275034,0.00005132705,0.008518887],"study_design_scores_gemma":[0.0016458003,0.00009157892,0.0009856543,0.00001734433,0.000032347092,0.000005597534,0.000010635311,0.0011041731,0.98709935,0.000010493902,0.008885566,0.000111441565],"about_ca_topic_score_codex":0.000069100955,"about_ca_topic_score_gemma":0.000016728529,"teacher_disagreement_score":0.010983059,"about_ca_system_score_codex":0.000004784347,"about_ca_system_score_gemma":0.00005589115,"threshold_uncertainty_score":0.3680984},"labels":[],"label_agreement":null},{"id":"W2081093096","doi":"10.1089/cbr.2000.15.7","title":"Radiobiology of Low-Dose-Rate Radiation Relevant to Radioimmunotherapy","year":2000,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Radioimmunotherapy; Radiobiology; Radiation therapy; Medicine; Dose rate; Nuclear medicine; Medical physics; External beam radiation; Oncology; Radiology; Immunology","score_opus":0.03380404522468958,"score_gpt":0.41157935055874234,"score_spread":0.3777753053340528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081093096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001330619,0.9920722,0.003867777,0.00014511231,0.00047596055,0.0023024315,0.00063124247,0.00012518301,0.00024698718],"genre_scores_gemma":[0.00003516643,0.9947037,0.0021303818,0.00061031914,0.0010366482,0.0007023073,0.00008098245,0.00021621972,0.0004842503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640214,0.00051113043,0.0012442734,0.00095202134,0.00018113003,0.00070932356],"domain_scores_gemma":[0.9979909,0.0003622678,0.0005862867,0.0006731481,0.000059105314,0.00032827907],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004312293,0.0009335691,0.0028712722,0.00044645253,0.00015171396,0.000050719813,0.00050548156,0.0004258188,0.0030680485],"category_scores_gemma":[0.0000048178736,0.00075520144,0.0006190512,0.0006710707,0.00038268373,0.00016416989,0.000031215743,0.0006190201,0.000012536867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018712599,0.00011007041,0.000026528389,0.0016421326,0.0010340096,0.0000029380817,0.00019308725,0.000014133353,0.0013083285,0.0009058288,0.0005309088,0.9940449],"study_design_scores_gemma":[0.0011719256,0.00019191961,0.000005780645,0.0030126106,0.00028919714,0.000010817209,0.0000046885975,0.000034176843,0.0017255855,0.00016557315,0.9925733,0.0008143916],"about_ca_topic_score_codex":0.00004741525,"about_ca_topic_score_gemma":2.8596284e-7,"teacher_disagreement_score":0.9932305,"about_ca_system_score_codex":0.00020424878,"about_ca_system_score_gemma":0.00033725594,"threshold_uncertainty_score":0.9994899},"labels":[],"label_agreement":null},{"id":"W2095513250","doi":"10.1089/cbr.2011.1059","title":"Relevance of the POS-1 Orthotopic Model as an “Imaging Model” for <i>In Vivo</i> and Simultaneous Monitoring of Tumor Proliferation and Bone Remodeling in Osteosarcoma","year":2012,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Bone remodeling; In vivo; Osteosarcoma; Medicine; Cancer research; Pathology; Internal medicine; Biology","score_opus":0.022889260729722832,"score_gpt":0.33583147173478806,"score_spread":0.31294221100506525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095513250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92248005,0.07578331,0.0009814376,0.000116062314,0.0001547093,0.00043912325,0.000032515065,0.0000030096694,0.000009783529],"genre_scores_gemma":[0.97100115,0.0266914,0.0016234671,0.00029059968,0.0002809276,0.000047321293,0.0000013051899,0.00001839386,0.00004546332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918747,0.00003355498,0.00025394428,0.0002311401,0.000074503696,0.00021936106],"domain_scores_gemma":[0.99963075,0.000028512057,0.00008330725,0.00013442177,0.000043450513,0.00007956357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024293091,0.00012680855,0.00021736788,0.000038720205,0.000046150417,0.000009457572,0.000058643403,0.00006824894,7.8995754e-7],"category_scores_gemma":[0.000030550455,0.00010364666,0.000031253134,0.00005856797,0.00011365378,0.000024866193,0.000024655665,0.00007885429,6.187661e-9],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044007492,0.00004598741,0.014727671,0.00012768232,0.000011293401,1.8940155e-7,0.00061239285,0.007458739,0.95566684,0.0001009869,0.0000026473278,0.020805504],"study_design_scores_gemma":[0.0019882387,0.0000497053,0.00047006278,0.000096263,0.000027333726,0.000018896859,0.000068666726,0.43868724,0.5569006,0.00017431947,0.0013570617,0.00016158157],"about_ca_topic_score_codex":0.000024755724,"about_ca_topic_score_gemma":0.000019637033,"teacher_disagreement_score":0.4312285,"about_ca_system_score_codex":0.000013689917,"about_ca_system_score_gemma":0.00006508189,"threshold_uncertainty_score":0.4226588},"labels":[],"label_agreement":null},{"id":"W2114783584","doi":"10.1089/cbr.2006.531","title":"Radiobiology of Systemic Radiation Therapy","year":2007,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Radiobiology; Medicine; Bystander effect; Radiation therapy; Clinical trial; Medical physics; Radionuclide therapy; Radioresistance; Systemic therapy; Clinical Practice; Mechanism (biology); Intensive care medicine; Cancer; Pathology; Nuclear medicine; Internal medicine; Immunology","score_opus":0.11488352530707849,"score_gpt":0.48632994069100177,"score_spread":0.3714464153839233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114783584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006197568,0.99596286,0.00004769697,0.00014161487,0.00069710385,0.002253167,0.00009765805,0.0000714438,0.00010867929],"genre_scores_gemma":[0.00030305036,0.9972578,0.000108563145,0.0008547171,0.000974505,0.00014560879,0.000060246923,0.00009669969,0.00019879891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976397,0.00030674078,0.0009223996,0.0005200484,0.00022566161,0.00038543504],"domain_scores_gemma":[0.9980993,0.0005240272,0.0005414013,0.00037699274,0.00009328726,0.0003649722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006866589,0.0005058521,0.0025894956,0.00045904322,0.000057177123,0.0000134392585,0.00015493103,0.0008218852,0.00037540018],"category_scores_gemma":[0.000048684728,0.00035951752,0.00047552967,0.00045217742,0.0002627651,0.00006368942,0.000012683924,0.0005125417,0.000009775238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002045256,0.00007095473,0.00013171636,0.015145575,0.0010119465,0.000017935006,0.00010312748,4.1020928e-7,0.0007859318,0.00014584923,0.00037383486,0.9820082],"study_design_scores_gemma":[0.0025177253,0.00037738937,0.000037705067,0.006540977,0.0007449265,0.00053547026,0.0000052655346,0.0000116107185,0.00058008166,0.0000036510016,0.9883251,0.00032010805],"about_ca_topic_score_codex":0.000007990413,"about_ca_topic_score_gemma":1.7760193e-7,"teacher_disagreement_score":0.9879513,"about_ca_system_score_codex":0.00022962577,"about_ca_system_score_gemma":0.00057525723,"threshold_uncertainty_score":0.9998857},"labels":[],"label_agreement":null},{"id":"W2116566846","doi":"10.1089/cbr.2007.0453","title":"Recombinant Human IL-24 Suppresses Lung Carcinoma Cell Growth via Induction of Cell Apoptosis and Inhibition of Tumor Angiogenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Angiogenesis; Lewis lung carcinoma; Cancer research; Biology; Peripheral blood mononuclear cell; Tumor necrosis factor alpha; In vivo; Transfection; Apoptosis; Cell culture; In vitro; Molecular biology; Immunology; Cancer; Metastasis","score_opus":0.027933573863687694,"score_gpt":0.31494605561314903,"score_spread":0.28701248174946137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116566846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97182935,0.02742957,0.00006230319,0.00011215438,0.00011785066,0.00032230993,0.00007431757,0.000007708301,0.000044456276],"genre_scores_gemma":[0.96327287,0.0361686,0.00011388409,0.00014683246,0.00013129837,0.000040273728,0.000023877647,0.000033667187,0.00006871486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875444,0.00014924438,0.00030300938,0.00037514023,0.00016002041,0.00025815828],"domain_scores_gemma":[0.9993837,0.000019565974,0.0001354329,0.0001994135,0.00012475839,0.00013712297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019244797,0.00019693859,0.00028752614,0.00011926578,0.00013910174,0.000008003644,0.00009656796,0.00014188566,0.00007272998],"category_scores_gemma":[0.0000045037887,0.00018038912,0.00009208914,0.00016866413,0.00042347005,0.000011020426,0.000040434352,0.0000968133,3.078844e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011169311,0.00015158909,0.008594317,0.00031838097,0.000071444534,0.000002523521,0.00016528828,0.0000044091175,0.9883652,0.000005273885,0.00028178323,0.00092290813],"study_design_scores_gemma":[0.002002292,0.0012221861,0.0019817834,0.000024639168,0.00003763719,0.000013645391,0.000032832075,0.000039203875,0.9940352,0.000024514244,0.00038486003,0.00020123414],"about_ca_topic_score_codex":0.00008220106,"about_ca_topic_score_gemma":0.0000045785832,"teacher_disagreement_score":0.008739033,"about_ca_system_score_codex":0.000022968867,"about_ca_system_score_gemma":0.00007653433,"threshold_uncertainty_score":0.7356055},"labels":[],"label_agreement":null},{"id":"W2176295651","doi":"10.1089/108497803322287727","title":"Design, Synthesis, and Evaluation of Radiolabeled Integrin α <sub> <i>v</i> </sub> β <sub>3</sub> Receptor Antagonists for Tumor Imaging and Radiotherapy","year":2003,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vitronectin; Alpha-v beta-3; Integrin; Antagonist; Receptor; Radiation therapy; Medicine; Cancer research; Alpha (finance); Chemistry; Nuclear medicine; Endocrinology; Internal medicine","score_opus":0.05024512640190948,"score_gpt":0.3744839929615905,"score_spread":0.32423886655968104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176295651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8633067,0.12829028,0.0040330836,0.0014105925,0.00019080851,0.0026475606,0.00004983495,0.000045168497,0.000025940564],"genre_scores_gemma":[0.84826875,0.14589548,0.0035214652,0.0014311674,0.0002091422,0.0005400482,0.000008810244,0.000113735005,0.0000113928945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966585,0.0007355739,0.00058984273,0.0007837942,0.00061444944,0.00061784463],"domain_scores_gemma":[0.9977604,0.0008396479,0.0001948629,0.0003161937,0.0003806293,0.0005082709],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026401887,0.00043310045,0.0008297137,0.00028811945,0.00021997737,0.000079622536,0.000111267225,0.00016766551,0.00010241432],"category_scores_gemma":[0.00032824549,0.00036671513,0.00012114727,0.0003475279,0.0006482277,0.00015901828,0.000022552893,0.0003457557,0.0000015213928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016410411,0.00012027023,0.0012541087,0.0003650782,0.00023347259,0.000007836398,0.00021208198,0.00000746639,0.74314517,0.0000637721,0.000491035,0.25245866],"study_design_scores_gemma":[0.0086248545,0.0003280613,0.00063179963,0.00033520898,0.00033354654,0.0001708501,0.000084044135,0.010586611,0.9710741,0.00008887338,0.0073643415,0.00037767628],"about_ca_topic_score_codex":0.0000069831985,"about_ca_topic_score_gemma":0.0000016296759,"teacher_disagreement_score":0.252081,"about_ca_system_score_codex":0.00028678557,"about_ca_system_score_gemma":0.00048177375,"threshold_uncertainty_score":0.99987847},"labels":[],"label_agreement":null},{"id":"W2178156564","doi":"10.1089/108497802320970271","title":"Fusion of the C <sub>H</sub> 1 Domain of IgG <sub>1</sub> to Epidermal Growth Factor (EGF) Prolongs its Retention in the Blood but Does Not Increase Tumor Uptake","year":2002,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Molecular biology; Fusion protein; Epidermal growth factor; Linker; Chemistry; Western blot; Transfection; Epidermal growth factor receptor; Biology; Receptor; Recombinant DNA; Biochemistry; Gene","score_opus":0.04591234637436718,"score_gpt":0.32581541232119043,"score_spread":0.27990306594682324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2178156564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781117,0.006836013,0.0000061225383,0.013020818,0.00016078276,0.0014112525,0.00034816124,0.00001564552,0.00008949243],"genre_scores_gemma":[0.9778408,0.017503321,0.00004923208,0.0040510376,0.00031120723,0.00010563745,0.000005047081,0.000027347247,0.00010641189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974482,0.00038440936,0.00060478796,0.00040921543,0.0006573684,0.0004960037],"domain_scores_gemma":[0.99883187,0.00027748971,0.0001708962,0.00028936059,0.00015492413,0.00027544078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066114165,0.00028147243,0.00053825934,0.00016398786,0.00016078605,0.00002192543,0.00028702023,0.00013560794,0.00018265477],"category_scores_gemma":[0.00011592442,0.00014033228,0.0002158927,0.00048358092,0.00041864233,0.0000966628,0.00007715499,0.0004542512,0.000005928626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019854957,0.00039088135,0.009098072,0.0005226545,0.0001402821,0.00005542359,0.0010456163,0.0000015036642,0.96825796,0.00025636333,0.0001541975,0.01809155],"study_design_scores_gemma":[0.0026575166,0.0003756123,0.06345306,0.00031608235,0.00009559062,0.00008886678,0.00007965802,0.00022195694,0.9309184,0.00006620062,0.0015542421,0.00017283036],"about_ca_topic_score_codex":0.00012755972,"about_ca_topic_score_gemma":0.00003085452,"teacher_disagreement_score":0.05435499,"about_ca_system_score_codex":0.000047131074,"about_ca_system_score_gemma":0.00008137285,"threshold_uncertainty_score":0.5722584},"labels":[],"label_agreement":null},{"id":"W2883711541","doi":"10.1089/cbr.2018.2480","title":"Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with <sup>188</sup> Rhenium","year":2018,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Cancer Institute","keywords":"Radioimmunotherapy; Chemistry; Antibody; Conjugate; Conjugated system; Radiochemistry; Reagent; Chelation; Monoclonal antibody; Cancer research; Medicine; Immunology; Organic chemistry; Polymer","score_opus":0.09331406033250034,"score_gpt":0.4293223009010369,"score_spread":0.33600824056853656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883711541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687431,0.026214741,0.0012704878,0.0015442391,0.00006222198,0.001527257,0.0000950302,0.000041766554,0.0005011435],"genre_scores_gemma":[0.98689276,0.008718237,0.0030134602,0.00051572017,0.0004982894,0.00019947701,0.000013624326,0.000041316584,0.00010712796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818486,0.00008058153,0.0005284545,0.00041690448,0.00046528122,0.00032389938],"domain_scores_gemma":[0.9981625,0.00021585463,0.00021493992,0.0002838873,0.0009007727,0.00022206036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010636683,0.0002542022,0.00065778685,0.00008526729,0.00016649679,0.000015214032,0.000113326,0.00014600868,0.00024853944],"category_scores_gemma":[0.00008291257,0.00019204005,0.00011676177,0.00029087698,0.0009022403,0.00009535967,0.00001403763,0.00017080805,0.0000011474111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033556772,0.00023725133,0.0014028765,0.00090316,0.000958632,9.626518e-7,0.0010721156,0.000094723255,0.95661634,0.00052647956,0.00021529356,0.034616463],"study_design_scores_gemma":[0.012247306,0.0005312423,0.00044610113,0.00036222977,0.0015974757,0.000036439007,0.00016511566,0.03181568,0.9437879,0.00015806741,0.008617679,0.00023481456],"about_ca_topic_score_codex":0.0000069350504,"about_ca_topic_score_gemma":8.053741e-7,"teacher_disagreement_score":0.034381647,"about_ca_system_score_codex":0.00007051545,"about_ca_system_score_gemma":0.00026950202,"threshold_uncertainty_score":0.7831166},"labels":[],"label_agreement":null},{"id":"W2888747994","doi":"10.1089/cbr.2018.2481","title":"Radioimmunotherapy as a Novel Approach in HIV, Bacterial, and Fungal Infectious Diseases","year":2018,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Radioimmunotherapy; Cryptococcus neoformans; Antimicrobial; Bacillus anthracis; Medicine; Human immunodeficiency virus (HIV); Pathogen; Immunology; Virology; Microbiology; Biology; Bacteria; Antibody; Monoclonal antibody","score_opus":0.06932892645915954,"score_gpt":0.42211489084561676,"score_spread":0.3527859643864572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888747994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023404625,0.99383,0.000073400224,0.00033060915,0.00020755074,0.0019626338,0.00036421075,0.00011649885,0.00077458535],"genre_scores_gemma":[0.00047923284,0.99508923,0.00025788194,0.0010713311,0.0014423938,0.00095518434,0.00011971085,0.00012886514,0.00045613752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722475,0.00012590377,0.00078385824,0.0010452654,0.00022958968,0.0005906608],"domain_scores_gemma":[0.9983945,0.00022843808,0.00021355414,0.00045569337,0.00005051634,0.00065731694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025328933,0.000761811,0.002162525,0.00022763749,0.00017803734,0.00011387889,0.00018149105,0.000610906,0.0005965362],"category_scores_gemma":[0.000026479698,0.00059570925,0.00032854534,0.0005631623,0.0008925259,0.00011673091,0.000049004237,0.00079175323,0.00001606965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009115672,0.001472637,0.00050483696,0.03123015,0.001792636,0.00006790488,0.0002314655,6.030025e-7,0.0042154323,0.00093617843,0.0010139992,0.9576226],"study_design_scores_gemma":[0.004657888,0.00012613811,0.00007711975,0.0035567381,0.0012751567,0.00114412,0.000009644025,0.00009722761,0.000222742,0.00002954897,0.9881532,0.00065046106],"about_ca_topic_score_codex":0.000011047859,"about_ca_topic_score_gemma":2.7150227e-7,"teacher_disagreement_score":0.9871392,"about_ca_system_score_codex":0.00025194554,"about_ca_system_score_gemma":0.00044827868,"threshold_uncertainty_score":0.9996494},"labels":[],"label_agreement":null},{"id":"W2906781095","doi":"10.1089/cbr.2018.2628","title":"An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells","year":2019,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision BioLogic (Canada)","funders":"","keywords":"Monoclonal antibody; Cytotoxicity; Antibody; Antibody-dependent cell-mediated cytotoxicity; Cancer research; Immunology; Biology; Chemistry; In vitro; Biochemistry","score_opus":0.013762383110684832,"score_gpt":0.3207886466733311,"score_spread":0.3070262635626463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906781095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684657,0.025593644,0.00012461738,0.00055233197,0.003443466,0.00079212856,0.00020080821,0.00012156398,0.0007057763],"genre_scores_gemma":[0.9701863,0.019364076,0.000006730245,0.00452091,0.00020010337,0.00004671817,0.00069437525,0.00005419369,0.0049265833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974176,0.00053169066,0.0005471633,0.0007135656,0.00011972659,0.00067023764],"domain_scores_gemma":[0.9989262,0.00017090573,0.00020953045,0.00046491035,0.00010884497,0.00011956545],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039138706,0.0004601259,0.0005213153,0.00012624149,0.00065801735,0.000121658166,0.0004114233,0.00042830617,0.0036845037],"category_scores_gemma":[0.0000053292747,0.00033327693,0.00015735484,0.00021019606,0.00045684242,0.00033162517,0.000044155586,0.00077347603,0.00034119032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064697507,0.0006446331,0.003355389,0.000046243356,0.00022202602,0.0000036997483,0.0004713261,0.000010072683,0.9889263,0.000036337897,0.004615275,0.0010217447],"study_design_scores_gemma":[0.0049407366,0.00039122856,0.0013291497,0.000028764132,0.000039381295,0.000019461437,0.000255798,0.00039760856,0.83620745,0.0000037250668,0.1559843,0.0004023923],"about_ca_topic_score_codex":0.0003584128,"about_ca_topic_score_gemma":0.000008655704,"teacher_disagreement_score":0.15271881,"about_ca_system_score_codex":0.0001136721,"about_ca_system_score_gemma":0.000088582194,"threshold_uncertainty_score":0.9999119},"labels":[],"label_agreement":null},{"id":"W2909850450","doi":"10.1089/cbr.2018.2566","title":"Lentivirus-Based Virus-Like Particles Mediate Delivery of Caspase 8 into Breast Cancer Cells and Inhibit Tumor Growth","year":2019,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Natural Science Foundation of China","keywords":"Apoptosis; Carcinogenesis; Cancer research; Cancer cell; Cancer; Programmed cell death; Breast cancer; Vesicular stomatitis virus; Cell growth; Biology; Caspase; Virus; Chemistry; Immunology; Biochemistry","score_opus":0.012012221459266203,"score_gpt":0.2864272114355402,"score_spread":0.27441498997627395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909850450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91808426,0.079684526,0.0000099254175,0.0007690533,0.00074274204,0.00032101915,0.00032934066,0.00003310018,0.000026002805],"genre_scores_gemma":[0.9676928,0.02935893,0.000024486624,0.0025074014,0.00004388331,0.00004477412,0.000005987694,0.000029102353,0.00029263322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858576,0.00024945507,0.0003469158,0.00037696122,0.000055599685,0.0003852984],"domain_scores_gemma":[0.9993337,0.00019494495,0.00013366649,0.0001734638,0.000087016,0.000077227145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022247792,0.00026281708,0.00045898787,0.00012852982,0.000110097244,0.000021616823,0.00013154285,0.00016022936,0.002286965],"category_scores_gemma":[0.000005234289,0.00020907828,0.00008993074,0.00013227208,0.0006641775,0.00013727437,0.00004605404,0.00023549877,0.000049340208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036997083,0.00012004869,0.0047655418,0.00018774207,0.00028132228,0.0000062766653,0.00042989868,0.0000038374815,0.978043,0.00008403075,0.00060242607,0.011776162],"study_design_scores_gemma":[0.0037512956,0.0001985978,0.0031640055,0.0001616854,0.00008437065,0.000026840618,0.00008800337,0.00008231411,0.97559446,0.000016183676,0.016562687,0.00026958392],"about_ca_topic_score_codex":0.00068728405,"about_ca_topic_score_gemma":0.00004269973,"teacher_disagreement_score":0.050325595,"about_ca_system_score_codex":0.000050637624,"about_ca_system_score_gemma":0.00014388337,"threshold_uncertainty_score":0.9986251},"labels":[],"label_agreement":null},{"id":"W2913881018","doi":"10.1089/cbr.2018.2732","title":"<i>In Vitro</i> Characterization of a Potent p53-MDM2 Inhibitor, RG7112 in Neuroblastoma Cancer Cell Lines","year":2019,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mdm2; Cancer research; Neuroblastoma; Cell culture; Ubiquitin ligase; Biology; Cell growth; Cell cycle; In vitro; Cancer cell; Cancer; Cell cycle checkpoint; Ubiquitin; Chemistry; Biochemistry; Genetics","score_opus":0.012083945139838782,"score_gpt":0.3017509563785083,"score_spread":0.2896670112386695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913881018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97383773,0.021884795,0.00002957383,0.002139763,0.0008295483,0.0009814206,0.000082874045,0.00002625219,0.00018805932],"genre_scores_gemma":[0.9407016,0.054654308,0.00005825792,0.0038395617,0.0002711554,0.00009721441,0.000013809416,0.000054020053,0.0003100572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984393,0.000076865945,0.00047418565,0.0004352184,0.00022391153,0.00035047828],"domain_scores_gemma":[0.99941134,0.00003197224,0.0001380081,0.00021802662,0.0000627559,0.00013789392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014959877,0.00024196965,0.00054127636,0.00018072534,0.000019080244,0.000012121802,0.000079088735,0.0001979853,0.00039816785],"category_scores_gemma":[0.0000051567176,0.000218955,0.00009221213,0.00040862986,0.000098982826,0.0001496657,0.000023617615,0.00030632538,0.000006870067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020044616,0.00023068208,0.0023065482,0.0003876164,0.00004208048,0.00003358381,0.00035134595,0.00006406186,0.9825617,0.000016213255,0.000045093988,0.011956579],"study_design_scores_gemma":[0.0069469805,0.00019741984,0.0056882645,0.0003924708,0.000046678364,0.000018602184,0.000019433774,0.0019229609,0.96633863,0.0000048870666,0.018203076,0.00022058943],"about_ca_topic_score_codex":0.00022442894,"about_ca_topic_score_gemma":0.00002787327,"teacher_disagreement_score":0.0331361,"about_ca_system_score_codex":0.00024281436,"about_ca_system_score_gemma":0.00020702796,"threshold_uncertainty_score":0.8928726},"labels":[],"label_agreement":null},{"id":"W2999126010","doi":"10.1089/cbr.2019.3141","title":"The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway","year":2020,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision BioLogic (Canada)","funders":"","keywords":"Cytotoxicity; Lymphokine-activated killer cell; Cancer research; NK-92; Biology; Antibody; Interleukin 21; Interleukin 12; Monoclonal antibody; Immune system; Cancer cell; Innate immune system; Natural killer cell; Carcinoembryonic antigen; Cell culture; Cytotoxic T cell; In vitro; Immunology; Cancer; T cell","score_opus":0.027605382548131486,"score_gpt":0.3385589504733103,"score_spread":0.3109535679251788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999126010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89415014,0.083593726,0.0000147119135,0.019576471,0.000898611,0.00089619705,0.000102108825,0.000038108912,0.0007299291],"genre_scores_gemma":[0.93197864,0.058602262,0.00015577795,0.0067413873,0.0010314963,0.000042126623,0.000010503356,0.00004454383,0.0013932884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972123,0.00023885418,0.0006894398,0.00052216684,0.0006711638,0.00066609774],"domain_scores_gemma":[0.99863094,0.00031142397,0.00024836167,0.00033676781,0.00012357219,0.000348922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003654593,0.00040367842,0.00064503244,0.000035187237,0.00052586925,0.000054430107,0.00044862935,0.00014619548,0.00024353692],"category_scores_gemma":[0.000034098965,0.00020877605,0.00041098776,0.00037641273,0.0013659296,0.000118818934,0.00017172632,0.0009989237,0.000013067159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017675947,0.0001445093,0.001407153,0.00036408947,0.00024205094,0.000030562558,0.0009374451,0.000010926859,0.9911456,0.000114667986,0.0008903746,0.002945026],"study_design_scores_gemma":[0.0018329001,0.0001976283,0.0033836572,0.0001472011,0.000050567945,0.000019975378,0.00014322872,0.0009509454,0.8478137,0.000028153276,0.1451925,0.00023953858],"about_ca_topic_score_codex":0.00008832684,"about_ca_topic_score_gemma":0.0000035020453,"teacher_disagreement_score":0.14430213,"about_ca_system_score_codex":0.000070770904,"about_ca_system_score_gemma":0.0003406237,"threshold_uncertainty_score":0.851364},"labels":[],"label_agreement":null},{"id":"W312288375","doi":"10.1089/cbr.2008.0595","title":"Y-90 Microsphere Therapy: Prevention of Adverse Events","year":2009,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Medicine; Microsphere; Leak; Emergency medicine; Surgery; Nuclear medicine; Anesthesia; Internal medicine; Environmental science","score_opus":0.11205657925206093,"score_gpt":0.5094028433593557,"score_spread":0.3973462641072948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W312288375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973292,0.015559469,0.0014631936,0.006246119,0.0007549942,0.0011431046,0.000039599407,0.00006538418,0.0014361665],"genre_scores_gemma":[0.9460613,0.046353504,0.00030283126,0.005406082,0.00020860221,0.000063656546,0.000009338563,0.000013101566,0.0015815943],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868524,0.0002351127,0.0004168838,0.00021458077,0.00016078154,0.0002874256],"domain_scores_gemma":[0.99926543,0.000080209626,0.00025417362,0.00016165413,0.00006930267,0.00016921834],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029117984,0.00013486156,0.00025489606,0.000045173318,0.00022756118,2.2250707e-7,0.000106108004,0.0001703267,0.0019870899],"category_scores_gemma":[0.000015429761,0.00010631822,0.000073763855,0.00016762517,0.00009882843,0.000112834015,0.0000086753125,0.00025069178,0.000016210352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037056105,0.0010186346,0.0970065,0.0004901502,0.00041968797,0.0000037790219,0.010336688,0.000070109694,0.46267465,0.004291025,0.0037050687,0.4162781],"study_design_scores_gemma":[0.01296221,0.00063427165,0.2762737,0.000906648,0.00007947315,0.0000027625392,0.0007188418,0.00026123787,0.02950387,0.0015511123,0.6766502,0.00045564165],"about_ca_topic_score_codex":0.000011760331,"about_ca_topic_score_gemma":0.0000017369297,"teacher_disagreement_score":0.67294514,"about_ca_system_score_codex":0.000058752194,"about_ca_system_score_gemma":0.00017061792,"threshold_uncertainty_score":0.9989252},"labels":[],"label_agreement":null},{"id":"W4223897956","doi":"10.1089/cbr.2021.0276","title":"Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals","year":2022,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Boron Compounds in Chemistry","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Neutron capture; Medicine; Prostate cancer; Boron; Cancer research; Cancer; Medical physics; Chemistry; Internal medicine","score_opus":0.10283845211229665,"score_gpt":0.4526838067473997,"score_spread":0.3498453546351031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223897956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010112068,0.99037844,0.000014045128,0.0014742375,0.0021755379,0.0033483799,0.00042616122,0.00029704004,0.0008749298],"genre_scores_gemma":[0.00076653366,0.9873407,0.0001776425,0.005897606,0.00234037,0.0010113044,0.00025081486,0.00044448228,0.001770532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99386925,0.0006468612,0.0013269427,0.0018264472,0.0010416671,0.0012888538],"domain_scores_gemma":[0.996634,0.00056169863,0.00052158517,0.0010594506,0.00008497107,0.001138308],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006110028,0.00160637,0.003653665,0.00029503249,0.00051586557,0.00015902362,0.00073517195,0.001171179,0.022044659],"category_scores_gemma":[0.000051372994,0.0012778189,0.0012762471,0.0006050927,0.00076401397,0.00015607182,0.00018367238,0.0029831817,0.000056337318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012642861,0.0006088551,0.000020852707,0.010007062,0.0029363208,0.0007290734,0.0002091116,0.000006190457,0.0037376294,0.000038374863,0.0023220237,0.9781202],"study_design_scores_gemma":[0.0063555054,0.00029754697,0.000017615675,0.0025441032,0.0026056527,0.0016864765,0.000035153495,0.00018897376,0.00077782484,0.000020165417,0.9842445,0.0012264388],"about_ca_topic_score_codex":0.00006173426,"about_ca_topic_score_gemma":4.5572003e-7,"teacher_disagreement_score":0.9819225,"about_ca_system_score_codex":0.0010139291,"about_ca_system_score_gemma":0.001261531,"threshold_uncertainty_score":0.9996684},"labels":[],"label_agreement":null},{"id":"W4297216557","doi":"10.1089/cbr.2022.0057","title":"Strategies for Preclinical Studies Evaluating the Biological Effects of an Accelerator-Based Boron Neutron Capture Therapy System","year":2022,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Boron Compounds in Chemistry","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Particle Physics","funders":"","keywords":"Neutron capture; Medicine; Medical physics; Head and neck; Clinical trial; Nuclear medicine; Neutron source; Cancer; Neutron; Surgery; Pathology; Internal medicine; Nuclear physics; Physics","score_opus":0.4739507947529298,"score_gpt":0.5819290519360126,"score_spread":0.10797825718308285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297216557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064054,0.987906,0.000015006503,0.00029946523,0.0008614313,0.004232281,0.00014823873,0.000104688865,0.000027505032],"genre_scores_gemma":[0.0023806712,0.99213874,0.00041871393,0.00075505726,0.0010648642,0.0030594796,0.00005948614,0.000098431614,0.000024570963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964393,0.00092634256,0.0009650886,0.00083817675,0.00038750598,0.00044362588],"domain_scores_gemma":[0.99415064,0.004328165,0.0005718919,0.0006232201,0.0001315078,0.00019457281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001379954,0.0006618486,0.0026950305,0.0000660325,0.00030854784,0.000057112247,0.00042865964,0.000560933,0.000105385145],"category_scores_gemma":[0.00010954617,0.0003564468,0.00061987544,0.00024145424,0.00070153223,0.00006629099,0.0000556278,0.0009532387,2.6034968e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016413387,0.00032329647,0.000012373459,0.08175824,0.002455417,0.000020542273,0.00028589784,0.000008996164,0.005281907,0.00022416956,0.00021113952,0.9077767],"study_design_scores_gemma":[0.00555202,0.0032481514,0.000009961045,0.00969344,0.002325595,0.00008459206,0.00076132047,0.00042567178,0.0028261042,0.00002821739,0.9744472,0.0005977466],"about_ca_topic_score_codex":0.000006842007,"about_ca_topic_score_gemma":4.840718e-7,"teacher_disagreement_score":0.974236,"about_ca_system_score_codex":0.00039167004,"about_ca_system_score_gemma":0.0011935504,"threshold_uncertainty_score":0.9998888},"labels":[],"label_agreement":null},{"id":"W4408160466","doi":"10.1089/cbr.2024.0202","title":"Diagnostic Value of <sup>99m</sup> Tc-Ubiquicidin Scintigraphy in Differentiating Bacterial from Nonbacterial Pneumonia","year":2025,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Pneumonia; Medicine; Scintigraphy; Bacterial pneumonia; Value (mathematics); Nuclear medicine; Radiology; Internal medicine; Computer science","score_opus":0.01457050027567186,"score_gpt":0.3390874867133751,"score_spread":0.3245169864377032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408160466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919802,0.004351864,0.00009828038,0.0017460322,0.00090529735,0.0005866624,0.0001365259,0.0000477069,0.00014742343],"genre_scores_gemma":[0.99069256,0.006991182,0.000056270615,0.0015492581,0.0005504541,0.00008584819,0.000014233732,0.000024351066,0.000035860452],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983519,0.00017244735,0.0005562737,0.00041775225,0.00015646977,0.00034519646],"domain_scores_gemma":[0.9989402,0.0004901237,0.00010717159,0.0002312191,0.000053755968,0.00017749946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016861677,0.00026549376,0.0006522276,0.00033481722,0.00011189518,0.00003850421,0.0001063362,0.00022435986,0.00042005468],"category_scores_gemma":[0.000097570344,0.00021805766,0.00015814957,0.00048321942,0.00029400355,0.00009379144,0.00003464911,0.00031361656,0.0000028128416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045397168,0.00022252933,0.23844783,0.00016385931,0.0002731617,0.000014643213,0.000306401,0.000031432282,0.75424266,0.00016220647,0.000057132347,0.0056241453],"study_design_scores_gemma":[0.010505586,0.00030832418,0.7606143,0.0012873812,0.0004499979,0.0000100475345,0.00007668769,0.0022913737,0.20460801,0.00022079147,0.01923154,0.00039599038],"about_ca_topic_score_codex":0.00018354267,"about_ca_topic_score_gemma":0.000017228405,"teacher_disagreement_score":0.5496347,"about_ca_system_score_codex":0.0000831693,"about_ca_system_score_gemma":0.00016531421,"threshold_uncertainty_score":0.8892133},"labels":[],"label_agreement":null}]}